US20080183283A1 - Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart - Google Patents
Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart Download PDFInfo
- Publication number
- US20080183283A1 US20080183283A1 US12/060,070 US6007008A US2008183283A1 US 20080183283 A1 US20080183283 A1 US 20080183283A1 US 6007008 A US6007008 A US 6007008A US 2008183283 A1 US2008183283 A1 US 2008183283A1
- Authority
- US
- United States
- Prior art keywords
- housing
- heart
- port
- lumen
- suture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
- A61B2017/3425—Access ports, e.g. toroid shape introducers for instruments or hands for internal organs, e.g. heart ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3439—Cannulas with means for changing the inner diameter of the cannula, e.g. expandable
- A61B2017/3441—Cannulas with means for changing the inner diameter of the cannula, e.g. expandable with distal sealing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
Definitions
- the present invention relates generally to an apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart. More particularly, the present invention relates to an apparatuses and methods for accessing the heart chamber and performing minimally invasive diagnostic and surgical procedures, including diagnosing and repairing pathology of the heart valves (aortic, mitral, pulmonary and tricuspid) and the cardiac chambers (atrial and ventricular septums), inside of a heart while the heart is still beating.
- the heart valves aortic, mitral, pulmonary and tricuspid
- the cardiac chambers atrial and ventricular septums
- septal defects i.e., holes in the walls of the cardiac chambers
- Several surgeons attempted to repair atrial septal defects in a beating heart by placing sutures blindly through the chamber walls or by working through atrial wells. These “wells” were created by “dams” sewn into the atrium. Once the well was constructed, the heart chamber was opened. The blood would rise a few centimeters up the walls of the well, due the pressure in the heart chamber. The relatively low pressure in the atrium, ranging from 2-20 mmHg, kept the blood from rising more than a few centimeters. The repair then was performed through the well.
- CPB cardiac surgery
- the standard CPB procedure requires opening the chest, placing the patient on CPB, and stopping the heart with cardioplegia.
- the heart itself is then opened and repaired.
- Heart valves replaced or repaired by various techniques, and defects in the atrial and ventricular septums can be sutured closed directly, or a patch can be sewn into place over the septum.
- the advances have not reduced the major complication rates, however, and they are associated with an increased risk of aortic dissection and stroke. Further, they increase the cost per case by approximately $5000. (8, 11).
- the major complication rate has not been reduced because the procedures have not eliminated the need for cardioplegia and CPB, which together account for the majority of the complications.
- Cardioplegia administered by one of several techniques, can minimize heart injury. (12). However, cardiac function is always depressed after cardioplegic arrest, and the longer the duration of arrest, the greater the injury. (13).
- CPB in its own right, can be damaging in multiple ways. CPB causes bleeding by disrupting hemostasis (blood clotting). CPB consumes platelets, activates fibrinogen, generates fibrin split products, activates the contact activation system, and dilutes formed and plasma clotting elements. (14-17). CPB also elicits a substantial whole body inflammatory response and generates large numbers of vasoactive substances. (17-19).
- the present invention is drawn to apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart that alleviate the need for cardiopulmonary bypass (CPB), minimizes the risk of air introduction into the heart during surgery and emboli, and maintains sufficient intracardial pressure during the diagnostic and surgical procedures.
- CPB cardiopulmonary bypass
- the apparatuses and methods are compatible with several types of diagnostic and surgical techniques, including mitral valve repair, repair of atrial or ventricular septal defects, endovascular aortic surgery, and electrophysiologic studies.
- a cardiac port for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart in accordance with the invention includes a housing, at least one valve, and an inlet.
- the housing has a first end, a second end, and a lumen therethrough.
- the valve is disposed in the housing to open and close the lumen.
- the inlet is connected to the housing.
- the inlet has an inlet passage in fluid communication with the lumen of the housing.
- the inlet is adapted to transmit a fluid between an exterior of the port and the lumen of the housing.
- a cardiac port for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart includes a housing, at least one valve, and first and second retainer members.
- the housing has a first end, a second end, and a lumen therethrough.
- the valve is disposed in the housing to open and close the lumen.
- the first and second retainer members are located on the housing.
- the first retainer member is spaced from the second retainer member a predetermined distance to anchor the chamber wall between the first and second retainer members.
- the first and second retainer members can comprise first and second flanges disposed on an exterior surface of the housing.
- an assembly for use in performing a medical procedure inside of a beating heart of a patient includes a port and a fluid transport device.
- the port in turn includes a housing having a first end, a second end, and a lumen therethrough; at least one valve disposed in the housing to open and close the lumen; and an inlet connected to the housing.
- the housing is configured for insertion through a chamber wall of a heart chamber so that the first end is exterior of the chamber wall and the second end is interior of the chamber wall.
- the inlet has an inlet passage in fluid communication with the lumen of the housing.
- the fluid transport device has one end that attaches to the inlet of the port, another end that attaches to a fluid source, and a fluid channel therebetween to pass a fluid from the fluid source to the inlet.
- the fluid passes from the inlet through the inlet passage and through the lumen into the heart chamber to maintain an intra-chamber pressure at a desired level.
- a method of accessing an interior of a heart chamber of a heart in accordance with the invention comprises the steps of maintaining beating of the heart, and inserting a port in a chamber wall of the heart chamber, the port having a lumen therethrough for accessing the interior of the heart chamber from exterior of the heart chamber.
- the inserting step can comprise securing the port in an atrial wall to access an interior of the heart.
- a method of preparing a beating heart for a diagnostic or medical procedure comprises the steps of inserting a port in a chamber wall of the beating heart, the port having a lumen to access to the heart chamber; and pressurizing the heart chamber with blood from a patient's artery.
- the method can include positioning a cannula through the chamber wall, and the pressurizing step can be accomplished by shunting arterial blood from the patient's artery into the heart chamber via the cannula.
- the pressurizing step can be accomplished by shunting arterial blood from the patient's artery into the heart chamber via the port.
- An apparatus for cutting a suture in accordance with the invention comprises an elongated body and a cutting implement.
- the elongated body, or sheath has a lumen, a wall member extending into the lumen, and a knot-receiving chamber defined by a first area on a first side of the wall member.
- the wall member defines a channel therethrough, where the channel is dimensioned to permit passage of a suture and to prevent passage of a knot.
- the cutting implement is movably disposed in the lumen in a second area on a second side of the wall member opposite the first side.
- the cutting implement is movable between a first position and second position to cut the suture.
- the suture cutting apparatus also can include an actuator to move the cutting implement between the first position and the second position.
- a method for repairing a damaged heart valve of a beating heart comprises the steps of inserting a valved port in a chamber wall of the beating heart to access an interior of a heart chamber; inserting a stapling device through the valved port; and positioning staples from the stapling device into at least a portion of the mitral valve annulus of the damaged heart valve to reduce a length of the portion of the mitral valve annulus.
- the method also can comprise the step of connecting the staples together with a strip of material. The positioning step can be accomplished by positioning the staples into the posterior mitral annulus.
- the apparatuses and methods of the present invention provide several advantages over known cardiac surgical instrumentation and procedures.
- the apparatuses and methods of the present invention alleviate the need for CPB or cardioplegic arrest by combining a cardiac port with advances in cardiac imaging and endoscopic suture placement devices and stapling devices and simplified valve and septal defect repair techniques.
- the cardiac port of the present invention is configured to be inserted through a chamber wall of a beating heart and to enable passage of medical instruments into a heart chamber, while minimizing injection of air into the heart chambers and consequent emboli.
- the method of the present invention provides access to a heart chamber via the cardiac port so that the surgical instruments can be inserted through the heart chamber to gain access to the operative site.
- TEE multiplane transesophageal echocardiography
- TEE images the mitral valve well enough to allow surgical manipulation of the valve via instruments, such as endoscopic suture placement devices, inserted into the heart chamber through the cardiac port.
- instruments such as endoscopic suture placement devices
- the endoscopic suture placement device can grasp the edge of a moving mitral valve leaflet and pass a suture through the valve leaflet.
- the endoscopic suture placement device in essence, sews the valve.
- This surgical technique involves suturing the free edges of the anterior and posterior mitral valves together to replicate an Alfiori (“bow tie”) mitral valve repair.
- the method of the present invention also enables investigation of the hemodynamic consequences of temporary acute mitral valve incompetence that will occur with valve manipulation.
- the apparatuses and methods of the present invention enable the surgeon to enter the heart through the atrium.
- the atrial approach allows the surgeon to place additional sutures and annuloplasty devices, including staples, sutures, and rings, in the appropriate locations in the heart.
- an atrial approach as compared to a ventricular approach, minimizes blood loss and maximizes the types of surgical techniques that can be performed.
- FIG. 1 is a side elevation view of a cardiac port in accordance with the invention.
- FIG. 1A is a side elevation view of the cardiac port of FIG. 1 with an obturator inserted therethrough.
- FIG. 2 is a side elevation view of a cardiac port in accordance with another embodiment of the invention.
- FIG. 2A is a side elevation view of the cardiac port of FIG. 2 with an obturator inserted therethrough.
- FIG. 3A schematically illustrates a patient placed in a right thoracotomy position.
- FIG. 3B schematically illustrates a right thoracotomy procedure.
- FIG. 3C schematically illustrates the patient's chest cavity C, as viewed in cross section, during a surgical procedure in accordance with the invention.
- FIG. 3D schematically illustrates the heart, viewed in the direction of arrow A in FIG. 4 , and shows one placement location of a cardiac port during a surgical procedure in accordance with the invention.
- FIG. 4 schematically illustrates the anatomy of a heart and shows placement of a cardiac port through the chamber wall of the left atrium.
- FIG. 5 schematically illustrates the anatomy of the heart.
- FIGS. 6A and 6B schematically illustrate the mitral valve, as seen from the left atrium.
- FIG. 7 schematically illustrates cardiac ports and obturators inserted through the chamber wall of the left atrium in preparation for a surgical procedure in accordance with the invention.
- FIG. 8 schematically illustrates cardiac ports inserted through the chamber wall of the left atrium in preparation for a surgical procedure in accordance with the invention.
- FIG. 9 schematically illustrates an endoscopic suture placing device inserted through a cardiac port.
- FIG. 9A schematically illustrates an endoscopic suture placing device inserted through a first cardiac port and a stabilizing device inserted through a second cardiac port.
- FIG. 9B schematically illustrates a mitral valve, where one leaflet of the mitral valve is engaged by an endoscopic suture placing device and a stabilizing device.
- FIG. 10 schematically illustrates suture placement in anterior and posterior leaflets of the mitral valve by an endoscopic suture placing device.
- FIG. 11 schematically illustrates suture location relative to the mitral valve and the cardiac port, following placement of the suture by an endoscopic suture placing device.
- FIG. 12 schematically illustrates insertion of an endoscopic knot pusher through a cardiac port, where the endoscopic knot pusher ties off the suture through the mitral valve.
- FIG. 13 schematically illustrates insertion of a suture cutting device through a cardiac port, where the suture cutting device cuts the suture.
- FIG. 14 schematically illustrates the anterior mitral leaflet and the posterior mitral leaflet sutured together.
- FIG. 15A schematically illustrates a damaged mitral valve, viewed from the left atrium.
- FIG. 15B schematically illustrates a repaired mitral valve, viewed from the left atrium.
- FIG. 16 is a side elevation view of a suture cutting device in accordance with the invention.
- FIG. 17 schematically illustrates a curved suture placement device inserted through a cardiac port to replace a chordea of the mitral valve.
- FIG. 18 schematically illustrates a stapling device inserted through a cardiac port during a stapled annuloplasty procedure in accordance with the invention.
- FIG. 19A schematically illustrates a damaged mitral valve prior to stapling, viewed from the left atrium.
- FIG. 19B schematically illustrates introduction of a stapling device toward a damaged mitral valve, viewed from the left atrium.
- FIG. 19C schematically illustrates a staple placed in the posterior mitral leaflet, which shortens the mitral leaflet at the staple location, viewed from the left atrium.
- FIG. 19D schematically illustrates a damaged mitral valve and staple placement, viewed from the left atrium.
- FIG. 19E schematically illustrates a repaired mitral valve after to stapling, viewed from the left atrium.
- FIG. 20A schematically illustrates a repaired mitral valve during systole.
- FIG. 20B schematically illustrates a repaired mitral valve during diastole.
- FIG. 21 schematically illustrates sutures extending from the posterior mitral annulus through a cardiac port and an annuloplasty device.
- FIG. 21A schematically illustrates a mitral valve having sutures extending through the posterior mitral annulus, as seen in FIG. 21 and as viewed from the left atrium.
- FIG. 22 schematically illustrates an annuloplasty ring implanted in the left atrium to encircle the mitral valve and cover the mitral annulus.
- FIG. 22A schematically illustrates a mitral valve encircled by an annuloplasty ring, as seen in FIG. 22 and as viewed from the left atrium.
- FIG. 22B schematically illustrates a mitral valve partially encircled by an alternative annuloplasty ring, as viewed from the left atrium.
- FIG. 23A schematically illustrates a staple prior to firing from a stapling device.
- FIG. 23B schematically illustrates a staple after firing from a stapling device.
- the present invention provides apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart, thereby obviating the need for administration of cardioplegia and cardiopulmonary bypass (CPB).
- Procedures contemplated by the present invention can include mitral and tricuspid valve repair, aortic and pulmonary valve repair, and repair of intracardiac defects, such as atrial and ventricular septal defects. Repair of the mitral valve in turn can include correcting mitral regurgitation (i.e., annular dilation and heart failure, myxomatous degeneration, and chordal rupture) and mitral stenosis.
- Other procedures include adjuncts to endovascular surgery and access for electrophysiologic studies.
- mitral regurgitation i.e., annular dilation and heart failure, myxomatous degeneration, and chordal rupture
- Other procedures include adjuncts to endovascular surgery and access for electrophysiologic studies.
- One of ordinary skill in the art will recognize other applications for the present apparatuses and methods.
- the present invention provides a valved cardiac port that can be temporarily inserted in a chamber wall of a heart chamber of a beating heart to provide access to the interior of the heart chamber from exterior of the heart chamber.
- the cardiac port is positioned through the wall of the left atrium.
- the atrium as opposed to the ventricle, is the preferred port of entry into the heart due to its anatomic position (i.e., enables access to the valve annulus, which is important in several valve repair techniques), low pressure, large surface area, lack of epicardial vessels to injure with port insertion, and relatively thin and flexible wall that facilitates instrument insertion and manipulation.
- the operative heart chamber can be kept pressurized with the patient's own blood. Pressurization is important to minimize the risk of air and/or particulates being introduced into the heart chamber and to minimize emboli.
- a catheter can be run between the patient's femoral or radial artery and the cardiac port to shunt the patient's blood into the cardiac chamber via the cardiac port.
- a catheter can be run between the femoral or radial artery to a cannula or a second port positioned at another location in the chamber wall, and the patient's blood can be introduced into the cardiac chamber via the cannula or the second port.
- a cardiac port generally indicated 10 .
- This cardiac port is configured for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart.
- the cardiac port 10 includes a housing 10 H having a first end 14 , a second end 16 , and a lumen 18 extending therethrough between the first end 14 and the second end 16 .
- medical instruments can be inserted through the lumen 18 and into the operative heart chamber, preferably the atria.
- the lumen 18 is shown having a uniform cross section, it will be understood that the lumen 18 can take various shapes and have a varied cross section. For example, the lumen can be wider at the first end 14 of the cardiac port 10 than at the second end 16 .
- the housing 10 H is configured for insertion through a heart chamber wall, preferably an atrial wall, of a beating heart, as will be described in more detail below.
- a heart chamber wall preferably an atrial wall, of a beating heart
- the port 10 also includes at least one valve 20 , and preferably two valves 20 , 21 , located in the housing 10 H to open and close the lumen 18 .
- the valves maintain a good seal against leakage of blood from, or air into, the heart chamber.
- the valves which are shown schematically in FIGS. 1 and 1A , can be one-way valves.
- valves 20 , 21 allow instruments to pass through the lumen 18 , but prevent blood from leaking out of the lumen 18 and air from going into the heart chamber through the lumen 18 . It is preferable that the valves 20 , 21 fit snugly against differently sized and shaped instruments so that, regardless of the shape/size of the instrument passing through the port, introduction of air into, and leakage of blood from, the heart chamber will be minimized.
- valve 20 nearer the first end 14 is a tight sealing valve that prevents air from leaking into the heart chamber
- valve 21 nearer the second end 16 is slightly looser than valve 20 and prevents blood from surging out of the heart chamber when a medical instrument or the like is passed through the lumen 18 .
- An inlet 22 can be connected to the housing 10 H at a location proximate valve 20 . Placement of the inlet 22 at this position is advantageous because any air in the heart chamber will rise to the most superior position, here, adjacent the valve 20 . Air bubbles trapped at a location at the underside of the valve 20 can be drawn out through the inlet 22 .
- the inlet 22 has an inlet passage 24 that is in fluid communication with the lumen 18 of the housing 10 H.
- the inlet 22 also has a de-airing/blood infusing stopcock 22 a that can be manually actuated to either allow air to flow out of the heart chamber or allow blood to be infused into the heart chamber.
- the inlet 22 is configured to transmit a fluid either from exterior of the port 10 to the lumen 18 of the housing 10 H or from the lumen 18 to exterior of the port 10 .
- a fluid transport device 26 such as a catheter or other fluid line, can be releasably attached to the inlet 22 at one end thereof.
- the other end of the catheter 26 can be attached to a fluid source, and a fluid channel extending between the ends of the catheter 26 passes fluid from the fluid source to the inlet 22 .
- the fluid then can pass from the inlet 22 through the inlet passage 24 and through the lumen 18 into the heart chamber to maintain the intra-chamber pressure at a desired level.
- the other end of the catheter 26 is inserted into an artery of the patient.
- Arterial blood can pass through the fluid channel of the catheter 26 from the patient's artery, through the inlet passage 24 of the inlet 22 , through the lumen 18 of the housing 10 H, and into the heart chamber. Providing arterial fluid to the heart chamber in this manner ensures that the pressure of the chamber remains at a sufficient pressure level.
- the atria normally are pressurized at 3-10 mmHg (i.e., 3-10 mmHg higher than atmospheric pressure), and, in disease states, they may be as high as 15-25 mmHg (i.e., 15-25 mmHg higher than atmospheric pressure).
- This supra-atmospheric pressure generally will create a column of blood in any device or cannula placed into the chamber, allowing the end of the cardiac port of the present invention to remain open and devices to be placed through it. Indeed, some early attempts at closure of atrial septal defects were done on the beating heart through an “atrial well.” With deep respiration, however, and when blood has been lost to surgery, the pressure can become sub-atmospheric, and air will be drawn into the cardiac chamber. By shuttling blood from the high-pressure arterial system having a mean pressure of 60-80 mmHg (i.e., 60-80 mmHg higher than atmospheric pressure) to the atrium, the pressure in the atrium will always remain above atmospheric pressure, and the risk of drawing air into the atrium is reduced.
- 60-80 mmHg i.e., 60-80 mmHg higher than atmospheric pressure
- the port 10 can be configured without an inlet 22 , or, for ports 10 having inlets 22 , the stopcock 22 a can remain closed.
- the housing 10 H includes a first portion 12 a and a second, narrower portion or neck 12 b .
- the valves 20 , 21 preferably are located in the first portion 12 a , and the inlet 22 preferably connects to the first portion 12 a .
- the cardiac port 10 can include additional valves (not shown) either in the first or second portions 12 a , 12 b .
- the neck 12 b has a diameter than is smaller than the diameter of the first portion 12 a . As shown in FIG. 1 , the neck 12 b is the part of the cardiac port 10 that extends through the heart chamber wall CW.
- the neck 12 b has a length that is substantially equal to or slightly greater than the chamber wall CW.
- the neck length will depend on which chamber the port is inserted through and at what angle. A preferred neck length can fall within the range of approximately 5 mm-1 cm.
- the neck 12 b is preferably flexible to conform to movement of the chamber wall CW as the heart beats.
- the right and left atria which are the envisioned placement sites of the cardiac port of the present invention, have very thin walls.
- the flexibility of the neck 12 b ensures that trauma to these thin walls is kept as minimal as possible. Neck flexibility also makes it easy for a surgeon to move the first end 14 of the port 10 to a position that facilitates insertion of instruments through the port 10 .
- the neck is not flexible, but rather is rigid.
- the port 10 preferably has first and second retainer members, such as annular flanges or surfaces created by shoulders of the housing, to retain the chamber wall CW therebetween.
- the second end 16 of the port 10 can include an outwardly extending flange 30 , preferably in the form of an annular ring.
- An upper surface 30 U of the flange 30 and a lower surface 12 LS of the upper portion 12 anchor the port 10 in place in the chamber wall CW.
- the flange 30 prevents inadvertent withdrawal of the port 10 from the chamber wall CW.
- a cardiac port assembly of the present invention can include a removable closure element 32 , such as an obturator, configured to pass through the lumen 18 of the cardiac port 10 , as shown in FIG. 1A .
- the obturator 32 dilates the initial stab wound through the heart chamber so that the port can be pushed through the chamber wall CW.
- the obturator 32 has a length sufficient such that, when the obturator 32 is fully inserted into the cardiac port 10 , a tapered tip 32 T extends through the second end 16 of the cardiac port 10 .
- the obturator 32 gradually dilates the atrial incision and, at the same time, by occupying the lumen 18 , prevents air from entering the heart chamber via lumen 18 in the port 10 .
- the port 10 preferably is made of a biocompatible, plastic material.
- the neck 12 b can be made of flexible plastic material or DACRON, for example, to be more flexible than the remaining portions of the port 10 .
- the cardiac port of the present invention can be manufactured in various sizes, depending on the size of the instruments to be inserted therethrough.
- FIGS. 2 and 2A show another embodiment of a cardiac port in accordance with the invention.
- the cardiac port 40 includes a housing 40 H that is generally cylindrical in shape.
- the cylindrical body of this port 40 as compared to port 10 , which has a larger diameter first portion 12 a than second portion 12 b , enables placement of a series of ports 40 or catheters through the chamber wall in relatively close proximity to each other.
- the smaller the diameter of the port 40 the more easily the port 40 can be tilted relative to the chamber wall CW.
- the smaller the diameter of the port 40 (and hence the narrower the profile of the port 40 ) the more likely it is that the port 40 can be placed through the chamber wall CW using thoracoscopic techniques, instead of via a full thoracotomy.
- the housing 40 H has a first end 14 ′, a second end 16 ′, and a lumen 18 ′ extending therethrough.
- the port 40 also includes at least one valve 20 ′, and preferably two valves 20 ′, 21 ′, located in the housing 10 H to open and close the lumen 18 ′, as explained above in connection with the embodiment of FIGS. 1 and 1A .
- An inlet 22 ′ is connected to the housing 40 H at a location proximate the valve 20 ′, and the inlet 22 ′ has an inlet passage 24 ′ that is in fluid communication with the lumen 18 ′ of the housing 40 H.
- the inlet 22 ′ also includes a de-airing/blood infusing stopcock 22 a ′ that can be manually actuated to either allow air to flow out of the heart chamber or allow blood to be infused into the heart chamber.
- a fluid transport device 26 such as a catheter, can be releasably attached to the inlet 22 ′ at one end and can be inserted into the artery of the patient at the opposite end to permit blood flow between the patient's artery and the heart chamber in the same manner as described above in connection with FIGS. 1 and 1A .
- the housing 40 H has a first flange 30 ′ at the second end 16 ′ of the housing 40 and a second flange 42 located on the housing at a location between the first and second ends 14 ′, 16 ′.
- An upper surface 30 U′ of the first flange 30 ′ and a lower surface 42 LS of the second flange 42 anchor the port 40 in place in the chamber wall CW.
- the flange 30 ′ prevents inadvertent withdrawal of the port 40 from the chamber wall CW.
- the length of the cardiac port 40 between the first and second flanges 30 ′, 42 which extends through the chamber wall CW, can be made of a flexible material, like neck 12 b in the embodiment of FIGS. 1 and 1A . In other embodiments, that length of the cardiac port 40 is made of an inflexible material.
- the second valve 21 ′ can be positioned within the lumen 18 ′ at a location between the first and second flanges 30 ′, 42 .
- the cardiac port assembly of FIGS. 2 and 2A can include a removable closure element 32 ′, for example, an obturator, configured to pass through the lumen 18 ′ of the cardiac port 40 , as shown in FIG. 2A .
- This obturator 32 ′ dilates the atrial incision and prevents air from entering the heart chamber during placement of cardiac port 40 into the chamber wall CW.
- cardiac port As mentioned above, during diagnostic and surgical procedures, medical instruments can be inserted through the lumen of the cardiac port.
- arterial blood is shunted from the femoral artery, or other suitable artery of the patient, via a catheter attached to the inlet of the port.
- the arterial blood then is passed into the heart chamber via the inlet passage of the inlet and the lumen.
- the cardiac port efficiently keeps the pressure elevated in the heart chamber using the patient's circulation as a pressure/energy source.
- the cardiac port of the present invention can be used in connection with imaging equipment for visualizing the beating heart during heart valve and septal defect surgery.
- the present invention contemplates repairing a beating heart using echocardiography or real-time CT scanning or magnetic resonance imaging (MRI) to “see” through the blood.
- Mitral valve repair for example, can be performed on the beating heart, without the use of CPB, through a combination of next generation imaging techniques, endoscopic suture placement devices, and simplified valve repair techniques.
- complex intracardiac and intravascular surgery can be performed on a closed chest patient under real-time three-dimensional imaging by robotic devices that are placed through the cardiac ports directly into the cardiac chambers.
- Multiplane transesophageal echo cardiography the current state of the art, has the capability of generating detailed two dimensional images of the mitral valve, including its leaflet edges and closure lines. (27; 28). TEE can provide accurate localization of regurgitant defects in the mitral valve. (29). Three dimensional echo imaging can provide even more detail, but that technique currently cannot be performed on the real-time basis required for surgical manipulation. (30). Advances in hardware and software suggest that this will be possible in the future, and the cardiac port of the present invention is designed to take advantage of these future advances in imaging technology.
- the cardiac port is designed to enable several standard surgical techniques to be performed as minimally invasive surgeries, including bow-tie repair, chordal replacement, and annuloplasty ring placement.
- the cardiac port of the present invention can be used to place sutures under the guidance of a standard TEE probe, and these sutures can be tied through the cardiac port.
- images be taken of a true short axis to provide the best working view of the mitral valve (short axis is shown in FIGS. 6A and 6B ), with selected long axis views to orient the instruments within the heart chamber (long axis is shown in FIG. 5 ).
- FIG. 3A the patient is placed in a right thoracotomy position, with the patient's left side down. This position minimizes the risk of drawing air in during the procedure.
- a right thoracotomy is performed, using single lung ventilation, as shown in FIG. 3B .
- the pericardium is opened and the left atrium exposed at the junction of the right pulmonary veins.
- the heart can be exposed in an identical manner utilizing thoracoscopic techniques, where the ports are placed using a thoracoscope. In all such techniques, low-dose systemic heparinization is utilized.
- the below-described procedure can be used in the future with yet-to-be-developed suture placement devices, knot tying techniques, and other instrumentation, including robotic technology.
- the open-chest thoracotomy procedure can be used to perform mitral valve repair and other minimally invasive diagnostic and surgical procedures inside of a beating heart.
- FIG. 3C is a schematic of the patient's chest cavity C, as viewed in cross section, during the surgical procedure.
- the patient's collapsed left lung CL, spine S, heart H, mitral valve MV, and preferred placement of the cardiac port P are shown in FIG. 3C .
- FIG. 3D illustrates the right and left atria RA, LA and the approximate placement of the cardiac port P through the chamber wall CW of the left atria LA during the thoracotomy procedure, which sets the stage for the mitral valve surgery in accordance with the invention.
- FIG. 4 illustrates the anatomy of the heart. Specifically, FIG. 4 shows the left atria LA, right atria RA, and mitral valve MV that separates the left atria LA and left ventricle LV.
- a block representing the cardiac port P is shown penetrating the chamber wall CW of the left atria LA. It will be understood that the port P shown in FIG. 4 and in the other figures is not necessarily to scale relative to the left atria LA.
- FIG. 5 also shows the anatomy of the heart. As best seen in FIG. 5 , the mitral valve MV includes an anterior mitral leaflet AML and a posterior mitral leaflet PML.
- FIGS. 6A and 6B schematically illustrate the mitral valve along its short axis, as seen from the left atrium.
- FIG. 6A shows a normal mitral valve in a closed position.
- FIG. 6B shows a leaking mitral valve.
- Encircling the mitral valve is the mitral valve annulus MVA.
- the mitral valve annulus is the structure that makes up the circumference or ring around the mitral valve.
- the anterior mitral annulus is defined as that portion of the mitral valve annulus from A to C.
- the posterior mitral annulus is defined as that portion of the mitral valve annulus from A to B to C. Leaking of the mitral valve can occur due to a torn chordea (labeled X 1 and X 2 in FIG.
- Leaking can also occur due to dilation of the posterior mitral annulus.
- the mitral valve leaflets no longer properly come into contact with one another, and the mitral valve leaks.
- FIG. 7 two cardiac ports 50 , 52 are shown inserted through the chamber wall CW of the left atrium LA.
- the ports 50 , 52 have the configuration of port 40 in FIGS. 2 and 2A , but it will be understood that ports having a different exterior configuration, such as that shown in FIGS. 1 and 1A , can be used in this surgical technique.
- the ports 50 , 52 Prior to their insertion through the chamber wall CW, the ports 50 , 52 are saline primed via their inlets 501 , 521 to remove all air from the central lumens of the ports 50 , 52 .
- Port 50 serves as a main working port.
- Port 52 is optional and, if inserted through the chamber wall CW, can serve as an auxiliary port to allow passage of a second set of instruments into the heart chamber.
- a pursestring suture is placed into the chamber wall CW at a desired entry point, and a stab wound is made in the center of the suture. The port and its obturator are then pushed through the stab wound.
- the respective obturators 54 a , 54 b are removed, and the ports are de-aired via the stopcocks of their inlets 501 , 521 .
- One end of a line 51 such as a catheter, is attached to the inlet 501 of port 50 , and the other end of line 51 is inserted percutaneously into a peripheral artery of the patient, such as the femoral artery (not shown).
- Blood flow through the line 51 and into the port 50 is adjusted by a variable occluder to maintain an atrial pressure of greater than 20 mmHg (i.e., 20 mmHg higher than atmospheric pressure).
- a variable occluder can include an adjustable clamp to regulate flow.
- a more sophisticated variable occluder can incorporate a pressure regulating device to keep the atrial pressure from rising to more than, for example, 25 mmHg (i.e., 25 mmHg higher than atmospheric pressure).
- Atrial pressure is transduced, or measured, through a fluid-filled line 53 placed into the most superior portion of the atrium. This line 53 also functions as another de-airing portal when low manual suction is applied to it.
- FIG. 8 shows a cannulated heart.
- a cannula or small tube can be positioned through the chamber wall, and the heart chamber can be pressurized by shunting arterial blood from the patient's artery into the heart chamber via the cannula.
- a transesophageal probe such as probe 55 in FIG. 7
- a sterile echo probe can be inserted directly into the pericardium beneath the heart in the space between the superior and inferior pulmonary veins.
- CT and MRI systems become available for operating room use, these will likely supplant TEE as the sole imaging modality.
- FIGS. 9-14 After identifying the anatomic structures on echo, and assessing the cause of the mitral valve dysfunction, repair is undertaken, as illustrated in FIGS. 9-14 .
- Stenotic mitral valves with commissural fusion where the valve leaflets fuse together, causing the valve opening to become narrow or “stenose,” are manually fractured with a spreading device placed through the port under direct echo guidance.
- the spreading device for example, endoscopic scissors, force the valve leaflet edges apart.
- Regurgitant valves i.e., valves which regurgitate blood from the ventricle to the atrium, will be treated in the following manner.
- an endoscopic suture placing device 56 is inserted through the main working cardiac port 50 .
- a customized valve hook device and/or grasper device 65 can be inserted through the second port 52 to stabilize the valve leaflets AML, PML and to facilitate suture placement by the suture placing device 56 .
- the suture has needles at both ends 57 , 58 .
- One end of the suture S remains outside of the patient's body under the control of the surgeon at all times to minimize the risk of the suture getting loose in the patient's circulatory system.
- FIG. 9 shows the needle on suture end 57 (obscured by device 56 ) being placed through the anterior mitral leaflet AML, with suture end 58 remaining outside of the patient's body.
- FIG. 10 shows the needle on suture end 58 (obscured by device 56 ) being placed through the posterior mitral leaflet PML, with suture end 57 remaining outside of the patient's body.
- the suture placing device 56 grasps the anterior leaflet AML at its free edge (the whole procedure being done under echo guidance) and fires the suture S through the anterior leaflet AML.
- the end 57 of the suture S that has just been fired through the anterior leaflet AML then is brought out of the left atrium LA by the suture placing device 56 via the port 50 .
- end 58 is loaded into the suturing device 56 , and the suture placing device 56 is fed back through the port 50 and into the left atrium LA.
- the appropriate section of the posterior leaflet PML then is grasped by the suture placing device 56 , and the suture end 58 is fired through the posterior leaflet PML, as shown in FIG. 10 .
- This end 58 of the suture S too is brought out through the port 50 , as shown in FIG. 11 .
- the suture S has two suture arms that terminate at ends 57 , 58 outside of the port 50 .
- the suture S is tied using a standard endoscopic knot pusher 59 , as shown in FIG. 12 .
- a suture cutting device 60 of the present invention is then run down one arm of the suture S, and the excess suture is trimmed, as shown in FIG. 13 .
- suture end 58 is shown extending from the suture cutting device 60 .
- the device 60 runs down over the suture arm S to avoid cutting other structures and is designed to cut each suture arm S at least 7 mm from the leaflets AML, PML, retaining a tail of at least 3 mm. This procedure avoids accidentally cutting the knot K.
- the suture cutting device 60 is illustrated in FIG. 16 and will be described more fully below. This suture cutting procedure is repeated down the other suture arm.
- Tying off the suture S in this manner leaves the central portions of the anterior and posterior mitral leaflets AML, PML sewn to one another in the manner of an Alfiori or “bow-tie” mitral valve repair, as seen in FIG. 14 and as is done in conventional open heart surgery. It will be understood that multiple sutures can be placed through the mitral leaflets, if necessary.
- the suture cutting device 60 is run down on suture arm at a time to reduce the chance of the knot K being cut.
- the suture cutting device can be run down both suture arms at the same time, and both suture arms then would be cut at the same time.
- FIGS. 15A and 15B show the mitral valve before and after the above-described surgical procedure.
- FIG. 15A shows a damaged mitral valve, where the leaflets AML, PML leak, and
- FIG. 15B shows the mitral valve in its repaired state following the surgical procedure.
- the cardiac ports of the present invention can be used in other surgical procedures. For example, if resecurement of one of the chordae to the papillary muscle PM of the ventricle is needed, a curved suture placement device 61 can be inserted through the lumen of port 50 and placed across the mitral valve MV, as shown in FIG. 17 . The suture placement device 61 then can be fired into the papillary muscle PM. The free ends of the suture then can be brought through the edge of the operative mitral leaflet (here, in FIG. 17 , the anterior mitral leaflet, although, in reality, it is usually the posterior mitral leaflet having the torn chord), as described above in connection with FIGS. 10-14 .
- the operative mitral leaflet here, in FIG. 17 , the anterior mitral leaflet, although, in reality, it is usually the posterior mitral leaflet having the torn chord
- a stapled annuloplasty can be performed in accordance with the invention.
- a stapling device 62 is placed through the cardiac port 50 , as shown in FIG. 18 .
- a row of staples ST is fired along the posterior mitral annulus, running from the left to the right fibrous trigones (approximately at A and C in FIGS. 5A and 5B ).
- the staples reduce the length of the posterior mitral annulus.
- the staples ST from the device 62 cover a distance of 10 mm when first pushed into the mitral annulus, as shown in FIG. 23A .
- Firing the device 62 causes the staples ST to fold in on themselves, as shown in FIG. 23B .
- FIGS. 19A-19E Points E and F in FIG. 19A are 10 mm apart before staple firing. Points E and F are 5 mm apart afterwards, as shown in FIG. 19C .
- FIG. 19B By varying the size of the anvil 62 A in the tip or head of the stapling device 62 , seen in FIG. 19B , varying amounts of folding will occur in the staple during firing. The greater the amount of folding that occurs in the staple, the greater the amount of tissue plication that will occur.
- the staple size and the anvil head size can be varied to change the amount of plication that occurs with staple firing.
- the staple placement can lead to a 30-40% reduction in the length of the posterior mitral annulus, as observed in conventional hand-sewn mitral annuloplasty.
- the stapling device 62 can be made in two types in accordance with the invention, one with individual staples, and one with staples that are connected to one another by a suture or band of material such as DACRON. This connection between staples may help to prevent delayed dilation of the annulus in the spaces between the sutures.
- FIGS. 20A and 20B show a completed mitral valve repair with two “bow-tie” sutures K placed between the anterior and posterior mitral leaflets AML, PML, and a stapled posterior annuloplasty, inserted in the manner described in connection with FIGS. 19D and 19E .
- FIG. 20A shows the mitral valve in systole (i.e., closed), and
- FIG. 20B shows the mitral valve in diastole (i.e., open).
- the staples ST are connected together by a strip of material M.
- the strip of material M can be DACRON or polyester, for example. The strip maintains the shape of the posterior valve annulus. Should the posterior valve annulus dilate over time between adjacent staples, the strip of material M prevents expansion of the posterior valve annulus from occurring.
- a stapled annuloplasty offers advantages over a conventional annuloplasty.
- reduction of the mitral valve annulus MVA is accomplished by plicating or folding the valve orifice down to a smaller size so that the valve leaflets come into better contact with one another.
- This reduction can be done with plicating sutures alone or with plicating sutures that are placed through an annuloplasty ring, which is a ring-shaped device of predetermined size, as will be described in more detail in connection with FIGS. 21-22 .
- staples are easier to place, and staples can be placed using less invasive techniques.
- a stapled annuloplasty therefore provides a technique more suitable for use on a beating heart.
- FIGS. 21 and 22 illustrate the placement of a conventional flexible annuloplasty device 64 , for example, an annuloplasty ring, through a cardiac port 50 of the present invention.
- the annuloplasty ring 64 is flexible and can be inserted through the cardiac port 50 in a sideways orientation.
- An endoscopic suture device is used to place multiple interrupted sutures through the posterior mitral annulus, as shown in FIG. 21A . Each of these sutures are brought through the annuloplasty ring 64 , as would be done in a conventional open mitral annuloplasty.
- the ring 64 then is flexed and pushed through the port 50 .
- the sutures then are tied using an endoscopic knot pusher 59 and cut with the suture cutting device 60 (see FIG. 16 ).
- the ring 64 remains seated against the mitral valve annulus as shown in FIGS. 22 and 22A .
- FIGS. 22 and 22A show an annuloplasty ring that completely encircles the mitral valve and covers the entire mitral annulus (i.e., both the anterior mitral annulus and posterior mitral annulus).
- the annuloplasty ring of FIGS. 22 and 22A can be replaced with an annuloplasty ring that only partially encircles the mitral valve.
- an annuloplasty ring for use in accordance with the invention will include rings 64 ′ that cover only the posterior mitral annulus, i.e., that portion of the valve annulus encircling the posterior mitral leaflet, as, for example, shown in FIG. 22B .
- the posterior mitral annulus is the portion of the mitral valve that usually dilates.
- the anterior mitral annulus usually does not dilate because it is attached to the fibrous central core of the heart, which generally remains the same size.
- FIG. 16 shows a suture cutting device 60 that can be used in the above-described surgical procedures in accordance with the invention.
- the suture cutting device 60 has an elongated body 60 B and a central lumen 60 C.
- the suture cutting device also includes a wall member 60 W extending into the lumen 60 C.
- the wall member 60 W separates a knot-receiving chamber 70 and a cutting implement 72 .
- the knot-receiving chamber 70 is defined by a first area on a first side of the wall member 60 W, and the cutting implement 72 is disposed in the lumen 60 C in a second area on an opposite side of the wall member 60 W.
- the elongated body 60 B serves as a protective sheath to isolate the cutting implement from the patient so that the cutting implement cannot cut or cause injury to the heart chamber or other anatomic structures.
- the wall member 60 W forms a narrowed portion having a hole or channel 60 CH therethrough.
- the channel 60 CH matches the caliber of the suture S.
- a strand of suture S i.e., a suture arm, can pass up through the channel 60 CH and out of the proximal end 60 PE of the device 60 .
- the elongated body 60 B can have a suture outlet opening located between the wall member 60 W and the proximal end 60 PE. The end 58 of the suture can pass through this suture outlet opening so that the suture does not need to be long enough to extend the entire length of the device 60 .
- the knot-receiving chamber 70 has a greater diameter than the channel 60 CH, such that knots K can be accommodated in the knot-receiving chamber 60 CH, but cannot pass through the channel 60 CH.
- the knot-receiving chamber can be approximately 7 mm in length, measured from the distal end 60 DE of the body 60 to a lower limit of the channel 60 H.
- the channel 60 CH has a length of approximately 3-5 mm.
- the suture cutting device 60 can be fired, for example, by actuating an actuator, such as push rod 90 , connected to the cutting implement 72 . Firing the suture cutting device 60 drives the cutting implement 72 from the first position to the second position across the suture S. Because the knot K cannot pass through the channel 60 CH, the cutting edge CE of the cutting implement cannot cut the knot K.
- the wall member 60 W can be annular in shape and can have planar upper and lower surfaces, angled upper and lower surfaces, or a combination thereof.
- the wall member 60 W is shown having an upper surface that is planar in one section 76 and angled in another section 78 .
- the cutting implement 72 can be disposed opposite the angled upper surface 78 .
- the cutting implement 72 can slide along the angled upper surface 78 of the wall member 60 W from a first (at rest) position, shown in FIG. 16 , to a second (cutting) position in the direction of arrow B.
- the wall member 60 W can have a surface 80 that acts as a stop for the cutting implement 72 . This stop surface 80 is located opposite the angled upper surface 78 .
- the cutting implement 72 will travel in the direction of arrow B only until cutting edge CE comes into contact with surface 80 .
- the cutting implement 72 then will retract to its first (at rest) position.
- the stapling device 62 , the suture cutting device 60 , and other medical devices used in the above-described minimally invasive diagnostic and surgical procedures can be attached to robotic arms or can be manually manipulated by the surgeon.
- the cardiac port of the present invention minimizes air intake into the cardiac chamber, minimizes the risk of emboli, and avoids excessive injury to the cardiac wall.
- the cardiac port prevents air intake by enabling pressurization of the heart chamber with the patient's own arterial blood.
- the port extends only a small distance into the intracardiac or intra-chamber area of the heart chamber to avoid inadvertent injury of the chamber wall or valve.
- the cardiac port may prevent blood loss because it includes at least one valve that prevents blood from leaking out of the cardiac port as instruments are passed through the lumen of the cardiac port.
- Suxamethonium (3 mg IV) will be given as a neuromuscular blocking agent.
- the femoral vein and both femoral arteries will be cannulated.
- Continuous pressure monitoring with a pressure transducer advanced to the thoracic aorta will be utilized.
- a left thoracotomy will be performed and the left lung deflated by hilar clamping. Heparin (100 mg/kg) will be given.
- a standard arterial line will be placed in the left femoral artery and connected, through a stopcock, into the left atrium via an 18 gauge IV catheter to increase left atrial pressure, which will minimize the risk of air introduction.
- Two purse-string sutures will be placed, one in the left atrial wall and one in the left atrial appendage. Cardiac ports in accordance with the invention will be inserted through the purse-strings and secured.
- a trans-esophageal echo (TEE) probe such as the OMINIPLANE device marketed by Hewlett-Packard, will be advanced into position and connected to a monitor, such as the SONOS 1000 marketed Hewlett-Packard. The left atrium will then be imaged (imaging planes chosen as described below). Under TEE guidance, the free edge of the posterior leaflet will be grasped, if needed, with an endoscopic grasper, such as a Genzyme Snowden-Pencer.
- a single mattress suture will be placed across the posterior leaflet by firing a stitching device, for example, the AUTO-STITCH device marketed by United States Surgical Corporation, or by firing an endoscopic suture placing device, which is an instrument that passes a single or double suture through a structure. The procedure will be repeated for the anterior leaflet. Both sutures will be brought out through the cardiac port. The sutures will be tied together through the port, using an endoscopic knot pusher. This will replicate the Alfiori “bow-tie” mitral valve repair.
- Mitral valve function will be examined using TEE.
- the mitral valve area will be calculated using a standard technique. In brief, under long-axis imaging, transmittal velocities will be measured by an echo Doppler. Using the modified Bernoulli equation, pressure gradients will be calculated. The mitral valve area then can be estimated, using the known pressure half time equation. Video recording will be made. Mitral regurgitation will be estimated by a standard color-flow Doppler technique, and regurgitant jet area and length will be measured.
- the swine will be euthanized with 30 cm of KCL.
- the mitral valve will be inspected for damage and accuracy of suture placement. It is expected that it will take 3-5 animals to develop the basic surgical technique. In animals 1-3, the emphasis will be on imaging and choosing proper port placement sites. Upper-esophageal, mid-esophageal and transgastric TEE positions will be evaluated. Multichamber imaging will be performed in multiple planes at each level. The appropriate imaging planes for surgical manipulation will be identified. Port placement sites on the atrium will be evaluated to choose which sites will allow the appropriate angles of approach to the dynamic valve without shadowing (blocking the echo signal).
- the beating heart valve surgery of the present invention represents a significant departure from current standard therapy. It has the potential to significantly reduce the morbidity and mortality of mitral valve surgery.
- mitral valve repair on the beating heart duplicating mitral valve repair techniques with a suturing device, and the substitution of echocardiography for direct visualization are all novel and unique approaches to cardiac surgery.
- These surgical techniques provide a stepping block for complex intracardiac repairs performed by small robotic devices placed into the heart using real-time three-dimensional echocardiography to guide the robotic devices.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
Abstract
The present invention provides apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart. An assembly for use in performing such a medical procedure includes a port and a fluid transport device. The port has a housing configured for insertion through a chamber wall of a heart chamber, at least one valve disposed in the housing, and an inlet connected to the housing. The inlet has an inlet passage in fluid communication with a lumen of the housing. The fluid transport device has an end that attaches to the inlet of the port, another end that attaches to a fluid source, and a fluid channel therebetween to pass a fluid from the fluid source to the heart chamber. A method of preparing a beating heart for a diagnostic or medical procedure comprises the steps of inserting a cardiac port through a chamber wall of the beating heart and pressurizing the heart chamber with blood from the patient's artery. Repair of the heart's mitral valve can be effected by a stapled annuloplasty procedure. Where sutures are used in the diagnostic or surgical procedure, a suture cutting device for cutting a suture inside a beating heart can be used. The suture cutting device can include an elongated body having a lumen, a wall member extending into the lumen, and a knot-receiving chamber defined by a first area on a first side of the wall member. The wall member defines a channel therethrough dimensioned to permit passage of a suture and to prevent passage of a knot. A cutting implement is movably disposed in the lumen in a second area on a second side of the wall member opposite the first side. The cutting implement moves between a first position and second position to cut the suture. Movement of the cutting implement is limited to ensure that the cutting implement does not cut through the suture knot.
Description
- This application claims the benefit of U.S. Provisional Application No. 60/212,075, filed Jun. 20, 2000, incorporated by reference herein in its entirety.
- The present invention relates generally to an apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart. More particularly, the present invention relates to an apparatuses and methods for accessing the heart chamber and performing minimally invasive diagnostic and surgical procedures, including diagnosing and repairing pathology of the heart valves (aortic, mitral, pulmonary and tricuspid) and the cardiac chambers (atrial and ventricular septums), inside of a heart while the heart is still beating.
- Diagnostic and reparative surgical procedures have been performed on the heart since at least the 1920s. The first attempts at repairing heart valves began in 1923 with Cutler and Levine performing blind dilations of the mitral valve with cutting instruments. These dilations were blind in that the patient's blood blocked the surgeon's sight to the valve. Thereafter, Sutar reported a successful dilation of a stenotic, or narrowed, mitral valve by inserting his finger through the atrium across the valve. The technique of digital dilation was improved and championed by Harken in 1948 and Bailey in 1949. Later, more effective instruments were developed, such the Tubbs dilator, which can be placed through a purse-string suture in either the atrium or the ventricle, passed across the valve, and dilated. These various techniques were somewhat effective to repair heart valves, but operating “blind” made precision impossible, and dilation often tore the valve, leading to valvular insufficiency. In addition, embolic brain and other organ injuries occurred due to air entering the heart chambers and to loosening calcific debris.
- The field of cardiac valve surgery did not develop significantly further until introduction, by Gibbon (1953) and by Lillehei and Kirklin (1955), of the heart-lung machine and cardiopulmonary bypass technique (CPB). With the body fully supported by CPB, the heart could be stopped with a protective cold blood potassium solution (cardioplegia) and opened, and more precise valve repairs and replacements could be performed under direct vision. At present, approximately 130,000 to 150,000 mitral valve procedures are performed annually. (1). All require full CPB, cardiac arrest, and a thoracic incision.
- The repair of septal defects, i.e., holes in the walls of the cardiac chambers, followed a similar course. Several surgeons attempted to repair atrial septal defects in a beating heart by placing sutures blindly through the chamber walls or by working through atrial wells. These “wells” were created by “dams” sewn into the atrium. Once the well was constructed, the heart chamber was opened. The blood would rise a few centimeters up the walls of the well, due the pressure in the heart chamber. The relatively low pressure in the atrium, ranging from 2-20 mmHg, kept the blood from rising more than a few centimeters. The repair then was performed through the well.
- Like the valve repairs, this procedure was a blind one, due to the surgeon's inability to see through blood that collected in the heart chamber. In addition, blood loss was unpredictable. Further, it was easy to entrain air into the cardiac chamber during this procedure, which could cause heart failure, strokes, and death. Several creative methods were devised to temporarily stop blood flow or briefly turn off the circulation or to support the circulation using another person's circulatory system, but these methods were cumbersome and dangerous, and only the simplest repairs could be performed. Safe and effective chamber wall repairs did not truly begin until introduction of the heart lung machine. The heart-lung machine supported circulation so that the surgeon could repair the septal defect under direct vision.
- With the advent of the heart-lung machine, CPB became the preferred method of cardiac surgery. The standard CPB procedure requires opening the chest, placing the patient on CPB, and stopping the heart with cardioplegia. The heart itself is then opened and repaired. Heart valves replaced or repaired by various techniques, and defects in the atrial and ventricular septums can be sutured closed directly, or a patch can be sewn into place over the septum.
- Despite advances, many open-heart surgical procedures still have a 5-9% mortality rate and a 20% morbidity rate. (2). In order to reduce morbidity, several “less invasive” approaches have been developed. Specialized clamps and cannulas allow the patient to be placed on CPB though smaller chest incisions or via a femoral approach. (3-8). Alterations in technique, new instruments, and the use of video have been utilized to further reduce incision size. (9). These advances improve patient satisfaction and may improve return-to-work rates. (6, 10).
- The advances have not reduced the major complication rates, however, and they are associated with an increased risk of aortic dissection and stroke. Further, they increase the cost per case by approximately $5000. (8, 11). The major complication rate has not been reduced because the procedures have not eliminated the need for cardioplegia and CPB, which together account for the majority of the complications.
- When the heart is stopped for surgery, it is cut off from its blood supply. Cardioplegia, administered by one of several techniques, can minimize heart injury. (12). However, cardiac function is always depressed after cardioplegic arrest, and the longer the duration of arrest, the greater the injury. (13). In addition to the risks associated with cardioplegia, CPB, in its own right, can be damaging in multiple ways. CPB causes bleeding by disrupting hemostasis (blood clotting). CPB consumes platelets, activates fibrinogen, generates fibrin split products, activates the contact activation system, and dilutes formed and plasma clotting elements. (14-17). CPB also elicits a substantial whole body inflammatory response and generates large numbers of vasoactive substances. (17-19). This leads to pulmonary dysfunction, third space loss, and neurohumoral imbalances. (17, 20). Additionally, CPB has negative effects on the immune system. (21). Furthermore, macroemboli produced during cannulation and aortic cross-clamping, as well as gaseous and particulate microemboli generated during the period of CPB, have been implicated in neurologic dysfunction seen frequently after open heart surgery. (22-24). A recent article in the New England Journal of Medicine reported that up to 6.1% of patients have adverse cerebral outcomes after cardiac surgery, with the majority of events attributable to CPB. (25).
- Several approaches have been developed to perform coronary artery bypass grafting on the beating heart using stabilization technologies. (26). These approaches eliminate the need for cardioplegia and CPB, reducing morbidity and per case cost. (20). Surgery of the interior of the heart is not possible with these methods, however, because the methods do not allow the cardiac chambers to be opened. To do surgery on the heart without CPB, the heart must continue to beat. Opening the cardiac chambers of a beating heart would lead to massive blood loss and air being drawn into the circulation in large amounts. Additionally, in order to directly visualize the area of surgical interest, the cardiac chamber must be free of blood. This cannot occur while the heart is beating.
- Cardiac surgery is undergoing a rapid evolution to less and less invasive procedures. Valve repairs and replacements can now be performed through significantly smaller incisions. Dr. Mehmet Oz at Columbia University has reported of a clip device that can be inserted through the apex of the left ventricle of the heart and clipped onto the leaflets of the mitral valve. (32). The clip effectively sews the anterior leaflet to the posterior leaflet. This clip technique mimics one type of mitral valve repair, called a “bow-tie” or Alfiori repair, and, as best understood, currently requires CPB. The clip technique has some potential drawbacks, however, including possible device embolization. In addition, entering the heart through the apex of the left ventricle increases the risk of blood loss due to the high intracavitary pressures of the ventricle and does not allow for any other work to be performed on the mitral valve.
- The present invention is drawn to apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart that alleviate the need for cardiopulmonary bypass (CPB), minimizes the risk of air introduction into the heart during surgery and emboli, and maintains sufficient intracardial pressure during the diagnostic and surgical procedures. In addition, the apparatuses and methods are compatible with several types of diagnostic and surgical techniques, including mitral valve repair, repair of atrial or ventricular septal defects, endovascular aortic surgery, and electrophysiologic studies.
- A cardiac port for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart in accordance with the invention includes a housing, at least one valve, and an inlet. The housing has a first end, a second end, and a lumen therethrough. The valve is disposed in the housing to open and close the lumen. The inlet is connected to the housing. The inlet has an inlet passage in fluid communication with the lumen of the housing. The inlet is adapted to transmit a fluid between an exterior of the port and the lumen of the housing.
- In another arrangement of the invention, a cardiac port for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart includes a housing, at least one valve, and first and second retainer members. The housing has a first end, a second end, and a lumen therethrough. The valve is disposed in the housing to open and close the lumen. The first and second retainer members are located on the housing. The first retainer member is spaced from the second retainer member a predetermined distance to anchor the chamber wall between the first and second retainer members. The first and second retainer members can comprise first and second flanges disposed on an exterior surface of the housing.
- In another aspect of the invention, an assembly for use in performing a medical procedure inside of a beating heart of a patient includes a port and a fluid transport device. The port in turn includes a housing having a first end, a second end, and a lumen therethrough; at least one valve disposed in the housing to open and close the lumen; and an inlet connected to the housing. The housing is configured for insertion through a chamber wall of a heart chamber so that the first end is exterior of the chamber wall and the second end is interior of the chamber wall. The inlet has an inlet passage in fluid communication with the lumen of the housing. The fluid transport device has one end that attaches to the inlet of the port, another end that attaches to a fluid source, and a fluid channel therebetween to pass a fluid from the fluid source to the inlet. The fluid passes from the inlet through the inlet passage and through the lumen into the heart chamber to maintain an intra-chamber pressure at a desired level.
- A method of accessing an interior of a heart chamber of a heart in accordance with the invention comprises the steps of maintaining beating of the heart, and inserting a port in a chamber wall of the heart chamber, the port having a lumen therethrough for accessing the interior of the heart chamber from exterior of the heart chamber. The inserting step can comprise securing the port in an atrial wall to access an interior of the heart.
- In still another aspect of the invention, a method of preparing a beating heart for a diagnostic or medical procedure comprises the steps of inserting a port in a chamber wall of the beating heart, the port having a lumen to access to the heart chamber; and pressurizing the heart chamber with blood from a patient's artery. The method can include positioning a cannula through the chamber wall, and the pressurizing step can be accomplished by shunting arterial blood from the patient's artery into the heart chamber via the cannula. In another arrangement, the pressurizing step can be accomplished by shunting arterial blood from the patient's artery into the heart chamber via the port.
- An apparatus for cutting a suture in accordance with the invention comprises an elongated body and a cutting implement. The elongated body, or sheath, has a lumen, a wall member extending into the lumen, and a knot-receiving chamber defined by a first area on a first side of the wall member. The wall member defines a channel therethrough, where the channel is dimensioned to permit passage of a suture and to prevent passage of a knot. The cutting implement is movably disposed in the lumen in a second area on a second side of the wall member opposite the first side. The cutting implement is movable between a first position and second position to cut the suture. The suture cutting apparatus also can include an actuator to move the cutting implement between the first position and the second position.
- A method for repairing a damaged heart valve of a beating heart in accordance with the invention comprises the steps of inserting a valved port in a chamber wall of the beating heart to access an interior of a heart chamber; inserting a stapling device through the valved port; and positioning staples from the stapling device into at least a portion of the mitral valve annulus of the damaged heart valve to reduce a length of the portion of the mitral valve annulus. The method also can comprise the step of connecting the staples together with a strip of material. The positioning step can be accomplished by positioning the staples into the posterior mitral annulus.
- The apparatuses and methods of the present invention provide several advantages over known cardiac surgical instrumentation and procedures. For example, the apparatuses and methods of the present invention alleviate the need for CPB or cardioplegic arrest by combining a cardiac port with advances in cardiac imaging and endoscopic suture placement devices and stapling devices and simplified valve and septal defect repair techniques. The cardiac port of the present invention is configured to be inserted through a chamber wall of a beating heart and to enable passage of medical instruments into a heart chamber, while minimizing injection of air into the heart chambers and consequent emboli. The method of the present invention provides access to a heart chamber via the cardiac port so that the surgical instruments can be inserted through the heart chamber to gain access to the operative site.
- The advances in cardiac imaging include multiplane transesophageal echocardiography (TEE). For example, in mitral valve repair, TEE images the mitral valve well enough to allow surgical manipulation of the valve via instruments, such as endoscopic suture placement devices, inserted into the heart chamber through the cardiac port. In one surgical technique, the endoscopic suture placement device can grasp the edge of a moving mitral valve leaflet and pass a suture through the valve leaflet. The endoscopic suture placement device, in essence, sews the valve. This surgical technique involves suturing the free edges of the anterior and posterior mitral valves together to replicate an Alfiori (“bow tie”) mitral valve repair. The method of the present invention also enables investigation of the hemodynamic consequences of temporary acute mitral valve incompetence that will occur with valve manipulation.
- In addition, the apparatuses and methods of the present invention enable the surgeon to enter the heart through the atrium. The atrial approach allows the surgeon to place additional sutures and annuloplasty devices, including staples, sutures, and rings, in the appropriate locations in the heart. Further, an atrial approach, as compared to a ventricular approach, minimizes blood loss and maximizes the types of surgical techniques that can be performed.
- These features and advantages, as well as other features and advantages, of the present invention will be set forth in the description that follows.
- These and other features, aspects, and advantages of the present invention will become apparent from the following detailed description, appended claims, and the accompanying exemplary embodiment shown in the drawings, which are briefly described below.
-
FIG. 1 is a side elevation view of a cardiac port in accordance with the invention. -
FIG. 1A is a side elevation view of the cardiac port ofFIG. 1 with an obturator inserted therethrough. -
FIG. 2 is a side elevation view of a cardiac port in accordance with another embodiment of the invention. -
FIG. 2A is a side elevation view of the cardiac port ofFIG. 2 with an obturator inserted therethrough. -
FIG. 3A schematically illustrates a patient placed in a right thoracotomy position. -
FIG. 3B schematically illustrates a right thoracotomy procedure. -
FIG. 3C schematically illustrates the patient's chest cavity C, as viewed in cross section, during a surgical procedure in accordance with the invention. -
FIG. 3D schematically illustrates the heart, viewed in the direction of arrow A inFIG. 4 , and shows one placement location of a cardiac port during a surgical procedure in accordance with the invention. -
FIG. 4 schematically illustrates the anatomy of a heart and shows placement of a cardiac port through the chamber wall of the left atrium. -
FIG. 5 schematically illustrates the anatomy of the heart. -
FIGS. 6A and 6B schematically illustrate the mitral valve, as seen from the left atrium. -
FIG. 7 schematically illustrates cardiac ports and obturators inserted through the chamber wall of the left atrium in preparation for a surgical procedure in accordance with the invention. -
FIG. 8 schematically illustrates cardiac ports inserted through the chamber wall of the left atrium in preparation for a surgical procedure in accordance with the invention. -
FIG. 9 schematically illustrates an endoscopic suture placing device inserted through a cardiac port. -
FIG. 9A schematically illustrates an endoscopic suture placing device inserted through a first cardiac port and a stabilizing device inserted through a second cardiac port. -
FIG. 9B schematically illustrates a mitral valve, where one leaflet of the mitral valve is engaged by an endoscopic suture placing device and a stabilizing device. -
FIG. 10 schematically illustrates suture placement in anterior and posterior leaflets of the mitral valve by an endoscopic suture placing device. -
FIG. 11 schematically illustrates suture location relative to the mitral valve and the cardiac port, following placement of the suture by an endoscopic suture placing device. -
FIG. 12 schematically illustrates insertion of an endoscopic knot pusher through a cardiac port, where the endoscopic knot pusher ties off the suture through the mitral valve. -
FIG. 13 schematically illustrates insertion of a suture cutting device through a cardiac port, where the suture cutting device cuts the suture. -
FIG. 14 schematically illustrates the anterior mitral leaflet and the posterior mitral leaflet sutured together. -
FIG. 15A schematically illustrates a damaged mitral valve, viewed from the left atrium. -
FIG. 15B schematically illustrates a repaired mitral valve, viewed from the left atrium. -
FIG. 16 is a side elevation view of a suture cutting device in accordance with the invention. -
FIG. 17 schematically illustrates a curved suture placement device inserted through a cardiac port to replace a chordea of the mitral valve. -
FIG. 18 schematically illustrates a stapling device inserted through a cardiac port during a stapled annuloplasty procedure in accordance with the invention. -
FIG. 19A schematically illustrates a damaged mitral valve prior to stapling, viewed from the left atrium. -
FIG. 19B schematically illustrates introduction of a stapling device toward a damaged mitral valve, viewed from the left atrium. -
FIG. 19C schematically illustrates a staple placed in the posterior mitral leaflet, which shortens the mitral leaflet at the staple location, viewed from the left atrium. -
FIG. 19D schematically illustrates a damaged mitral valve and staple placement, viewed from the left atrium. -
FIG. 19E schematically illustrates a repaired mitral valve after to stapling, viewed from the left atrium. -
FIG. 20A schematically illustrates a repaired mitral valve during systole. -
FIG. 20B schematically illustrates a repaired mitral valve during diastole. -
FIG. 21 schematically illustrates sutures extending from the posterior mitral annulus through a cardiac port and an annuloplasty device. -
FIG. 21A schematically illustrates a mitral valve having sutures extending through the posterior mitral annulus, as seen inFIG. 21 and as viewed from the left atrium. -
FIG. 22 schematically illustrates an annuloplasty ring implanted in the left atrium to encircle the mitral valve and cover the mitral annulus. -
FIG. 22A schematically illustrates a mitral valve encircled by an annuloplasty ring, as seen inFIG. 22 and as viewed from the left atrium. -
FIG. 22B schematically illustrates a mitral valve partially encircled by an alternative annuloplasty ring, as viewed from the left atrium. -
FIG. 23A schematically illustrates a staple prior to firing from a stapling device. -
FIG. 23B schematically illustrates a staple after firing from a stapling device. - The present invention provides apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart, thereby obviating the need for administration of cardioplegia and cardiopulmonary bypass (CPB). Procedures contemplated by the present invention can include mitral and tricuspid valve repair, aortic and pulmonary valve repair, and repair of intracardiac defects, such as atrial and ventricular septal defects. Repair of the mitral valve in turn can include correcting mitral regurgitation (i.e., annular dilation and heart failure, myxomatous degeneration, and chordal rupture) and mitral stenosis. Other procedures include adjuncts to endovascular surgery and access for electrophysiologic studies. One of ordinary skill in the art will recognize other applications for the present apparatuses and methods.
- In this connection, the present invention provides a valved cardiac port that can be temporarily inserted in a chamber wall of a heart chamber of a beating heart to provide access to the interior of the heart chamber from exterior of the heart chamber. In a preferred embodiment, the cardiac port is positioned through the wall of the left atrium. The atrium, as opposed to the ventricle, is the preferred port of entry into the heart due to its anatomic position (i.e., enables access to the valve annulus, which is important in several valve repair techniques), low pressure, large surface area, lack of epicardial vessels to injure with port insertion, and relatively thin and flexible wall that facilitates instrument insertion and manipulation.
- In another aspect of the invention, the operative heart chamber can be kept pressurized with the patient's own blood. Pressurization is important to minimize the risk of air and/or particulates being introduced into the heart chamber and to minimize emboli. In a first technique, a catheter can be run between the patient's femoral or radial artery and the cardiac port to shunt the patient's blood into the cardiac chamber via the cardiac port. In a second technique, a catheter can be run between the femoral or radial artery to a cannula or a second port positioned at another location in the chamber wall, and the patient's blood can be introduced into the cardiac chamber via the cannula or the second port.
- With reference to the figures, wherein identical numerals indicate identical parts, and in particular to
FIGS. 1 and 1A , a cardiac port, generally indicated 10, is shown. This cardiac port is configured for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart. Thecardiac port 10 includes ahousing 10H having afirst end 14, asecond end 16, and alumen 18 extending therethrough between thefirst end 14 and thesecond end 16. During diagnostic and surgical procedures, medical instruments can be inserted through thelumen 18 and into the operative heart chamber, preferably the atria. Although thelumen 18 is shown having a uniform cross section, it will be understood that thelumen 18 can take various shapes and have a varied cross section. For example, the lumen can be wider at thefirst end 14 of thecardiac port 10 than at thesecond end 16. - The
housing 10H is configured for insertion through a heart chamber wall, preferably an atrial wall, of a beating heart, as will be described in more detail below. When inserted, thefirst end 14 of thehousing 10H remains exteriorly of the atrial wall, and thesecond end 16 is positioned interiorly of the atrial wall. Theport 10 also includes at least onevalve 20, and preferably twovalves housing 10H to open and close thelumen 18. The valves maintain a good seal against leakage of blood from, or air into, the heart chamber. The valves, which are shown schematically inFIGS. 1 and 1A , can be one-way valves. Thesevalves lumen 18, but prevent blood from leaking out of thelumen 18 and air from going into the heart chamber through thelumen 18. It is preferable that thevalves valve 20 nearer thefirst end 14 is a tight sealing valve that prevents air from leaking into the heart chamber, andvalve 21 nearer thesecond end 16 is slightly looser thanvalve 20 and prevents blood from surging out of the heart chamber when a medical instrument or the like is passed through thelumen 18. - An
inlet 22 can be connected to thehousing 10H at a locationproximate valve 20. Placement of theinlet 22 at this position is advantageous because any air in the heart chamber will rise to the most superior position, here, adjacent thevalve 20. Air bubbles trapped at a location at the underside of thevalve 20 can be drawn out through theinlet 22. In this regard, theinlet 22 has aninlet passage 24 that is in fluid communication with thelumen 18 of thehousing 10H. Theinlet 22 also has a de-airing/blood infusing stopcock 22 a that can be manually actuated to either allow air to flow out of the heart chamber or allow blood to be infused into the heart chamber. In this regard, theinlet 22 is configured to transmit a fluid either from exterior of theport 10 to thelumen 18 of thehousing 10H or from thelumen 18 to exterior of theport 10. - A
fluid transport device 26, such as a catheter or other fluid line, can be releasably attached to theinlet 22 at one end thereof. The other end of thecatheter 26 can be attached to a fluid source, and a fluid channel extending between the ends of thecatheter 26 passes fluid from the fluid source to theinlet 22. The fluid then can pass from theinlet 22 through theinlet passage 24 and through thelumen 18 into the heart chamber to maintain the intra-chamber pressure at a desired level. In one embodiment, the other end of thecatheter 26 is inserted into an artery of the patient. Arterial blood can pass through the fluid channel of thecatheter 26 from the patient's artery, through theinlet passage 24 of theinlet 22, through thelumen 18 of thehousing 10H, and into the heart chamber. Providing arterial fluid to the heart chamber in this manner ensures that the pressure of the chamber remains at a sufficient pressure level. - This pressurization of the heart chamber with arterial blood minimizes the risk of air induction when medical instruments are introduced into the heart chamber through the
cardiac port 10. A major concern with placement of any device into the heart is the potential for induction of air, particularly into the left side of the circulation pathway. The air could be embolized, systemically leading to stroke, organ ischemia, and death. The atria normally are pressurized at 3-10 mmHg (i.e., 3-10 mmHg higher than atmospheric pressure), and, in disease states, they may be as high as 15-25 mmHg (i.e., 15-25 mmHg higher than atmospheric pressure). This supra-atmospheric pressure generally will create a column of blood in any device or cannula placed into the chamber, allowing the end of the cardiac port of the present invention to remain open and devices to be placed through it. Indeed, some early attempts at closure of atrial septal defects were done on the beating heart through an “atrial well.” With deep respiration, however, and when blood has been lost to surgery, the pressure can become sub-atmospheric, and air will be drawn into the cardiac chamber. By shuttling blood from the high-pressure arterial system having a mean pressure of 60-80 mmHg (i.e., 60-80 mmHg higher than atmospheric pressure) to the atrium, the pressure in the atrium will always remain above atmospheric pressure, and the risk of drawing air into the atrium is reduced. - In some instances, it may not be necessary to pressurize the atrium with arterial blood. For those instances, the
port 10 can be configured without aninlet 22, or, forports 10 havinginlets 22, the stopcock 22 a can remain closed. - In the embodiment shown in
FIGS. 1 and 1A , thehousing 10H includes afirst portion 12 a and a second, narrower portion orneck 12 b. Thevalves first portion 12 a, and theinlet 22 preferably connects to thefirst portion 12 a. Thecardiac port 10 can include additional valves (not shown) either in the first orsecond portions neck 12 b has a diameter than is smaller than the diameter of thefirst portion 12 a. As shown inFIG. 1 , theneck 12 b is the part of thecardiac port 10 that extends through the heart chamber wall CW. When thecardiac port 10 is inserted through the heart chamber wall, it is important that the portion of theport 10 that extends into the heart chamber does not unintentionally contact heart tissue or heart valves or interfere with the beating of the heart. Accordingly, theneck 12 b has a length that is substantially equal to or slightly greater than the chamber wall CW. The neck length will depend on which chamber the port is inserted through and at what angle. A preferred neck length can fall within the range of approximately 5 mm-1 cm. In addition, theneck 12 b is preferably flexible to conform to movement of the chamber wall CW as the heart beats. The right and left atria, which are the envisioned placement sites of the cardiac port of the present invention, have very thin walls. The flexibility of theneck 12 b ensures that trauma to these thin walls is kept as minimal as possible. Neck flexibility also makes it easy for a surgeon to move thefirst end 14 of theport 10 to a position that facilitates insertion of instruments through theport 10. In other embodiments, the neck is not flexible, but rather is rigid. - The
port 10 preferably has first and second retainer members, such as annular flanges or surfaces created by shoulders of the housing, to retain the chamber wall CW therebetween. For example, thesecond end 16 of theport 10 can include an outwardly extendingflange 30, preferably in the form of an annular ring. Anupper surface 30U of theflange 30 and a lower surface 12LS of the upper portion 12 anchor theport 10 in place in the chamber wall CW. Theflange 30 prevents inadvertent withdrawal of theport 10 from the chamber wall CW. - A cardiac port assembly of the present invention can include a
removable closure element 32, such as an obturator, configured to pass through thelumen 18 of thecardiac port 10, as shown inFIG. 1A . Theobturator 32 dilates the initial stab wound through the heart chamber so that the port can be pushed through the chamber wall CW. Theobturator 32 has a length sufficient such that, when theobturator 32 is fully inserted into thecardiac port 10, a taperedtip 32T extends through thesecond end 16 of thecardiac port 10. During placement of thecardiac port 10 through the heart chamber wall CW, theobturator 32 gradually dilates the atrial incision and, at the same time, by occupying thelumen 18, prevents air from entering the heart chamber vialumen 18 in theport 10. - The
port 10 preferably is made of a biocompatible, plastic material. Theneck 12 b can be made of flexible plastic material or DACRON, for example, to be more flexible than the remaining portions of theport 10. The cardiac port of the present invention can be manufactured in various sizes, depending on the size of the instruments to be inserted therethrough. -
FIGS. 2 and 2A show another embodiment of a cardiac port in accordance with the invention. Thecardiac port 40 includes ahousing 40H that is generally cylindrical in shape. The cylindrical body of thisport 40, as compared toport 10, which has a larger diameterfirst portion 12 a thansecond portion 12 b, enables placement of a series ofports 40 or catheters through the chamber wall in relatively close proximity to each other. In addition, the smaller the diameter of theport 40, the more easily theport 40 can be tilted relative to the chamber wall CW. Also, the smaller the diameter of the port 40 (and hence the narrower the profile of the port 40), the more likely it is that theport 40 can be placed through the chamber wall CW using thoracoscopic techniques, instead of via a full thoracotomy. - The
housing 40H has afirst end 14′, asecond end 16′, and alumen 18′ extending therethrough. Theport 40 also includes at least onevalve 20′, and preferably twovalves 20′, 21′, located in thehousing 10H to open and close thelumen 18′, as explained above in connection with the embodiment ofFIGS. 1 and 1A . - An
inlet 22′ is connected to thehousing 40H at a location proximate thevalve 20′, and theinlet 22′ has aninlet passage 24′ that is in fluid communication with thelumen 18′ of thehousing 40H. Theinlet 22′ also includes a de-airing/blood infusing stopcock 22 a′ that can be manually actuated to either allow air to flow out of the heart chamber or allow blood to be infused into the heart chamber. Afluid transport device 26, such as a catheter, can be releasably attached to theinlet 22′ at one end and can be inserted into the artery of the patient at the opposite end to permit blood flow between the patient's artery and the heart chamber in the same manner as described above in connection withFIGS. 1 and 1A . - The
housing 40H has afirst flange 30′ at thesecond end 16′ of thehousing 40 and asecond flange 42 located on the housing at a location between the first and second ends 14′, 16′. Anupper surface 30U′ of thefirst flange 30′ and a lower surface 42LS of thesecond flange 42 anchor theport 40 in place in the chamber wall CW. Theflange 30′ prevents inadvertent withdrawal of theport 40 from the chamber wall CW. The length of thecardiac port 40 between the first andsecond flanges 30′, 42, which extends through the chamber wall CW, can be made of a flexible material, likeneck 12 b in the embodiment ofFIGS. 1 and 1A . In other embodiments, that length of thecardiac port 40 is made of an inflexible material. - In this embodiment, the
second valve 21′ can be positioned within thelumen 18′ at a location between the first andsecond flanges 30′, 42. Like in the embodiment ofFIGS. 1 and 1A , the cardiac port assembly ofFIGS. 2 and 2A can include aremovable closure element 32′, for example, an obturator, configured to pass through thelumen 18′ of thecardiac port 40, as shown inFIG. 2A . Thisobturator 32′ dilates the atrial incision and prevents air from entering the heart chamber during placement ofcardiac port 40 into the chamber wall CW. - As mentioned above, during diagnostic and surgical procedures, medical instruments can be inserted through the lumen of the cardiac port. At the same time, arterial blood is shunted from the femoral artery, or other suitable artery of the patient, via a catheter attached to the inlet of the port. The arterial blood then is passed into the heart chamber via the inlet passage of the inlet and the lumen. By shunting the patient's own arterial blood into the inlet, the cardiac port efficiently keeps the pressure elevated in the heart chamber using the patient's circulation as a pressure/energy source.
- Because the present invention involves performance of diagnostic and surgical procedures inside of a beating heart, and because these procedures are minimally invasive (as opposed to open heart procedures), the defect or chamber wall being evaluated or needing repair often is obscured by the patient's organs, tissue, and blood. Accordingly, the cardiac port of the present invention can be used in connection with imaging equipment for visualizing the beating heart during heart valve and septal defect surgery. The present invention contemplates repairing a beating heart using echocardiography or real-time CT scanning or magnetic resonance imaging (MRI) to “see” through the blood. Mitral valve repair, for example, can be performed on the beating heart, without the use of CPB, through a combination of next generation imaging techniques, endoscopic suture placement devices, and simplified valve repair techniques. According to the present invention, complex intracardiac and intravascular surgery can be performed on a closed chest patient under real-time three-dimensional imaging by robotic devices that are placed through the cardiac ports directly into the cardiac chambers.
- Multiplane transesophageal echo cardiography (TEE), the current state of the art, has the capability of generating detailed two dimensional images of the mitral valve, including its leaflet edges and closure lines. (27; 28). TEE can provide accurate localization of regurgitant defects in the mitral valve. (29). Three dimensional echo imaging can provide even more detail, but that technique currently cannot be performed on the real-time basis required for surgical manipulation. (30). Advances in hardware and software suggest that this will be possible in the future, and the cardiac port of the present invention is designed to take advantage of these future advances in imaging technology.
- In the past, standard mitral valve repair techniques involved resecting areas of redundant valve leaflets and mechanically reducing the valve annulus, thus improving leaflet edge coaptation to restore valve competence. The Alfiori method involves fixing the redundant section of a leaflet to the opposite valve edge. This recently described technique has been demonstrated to be effective and is technically simple enough to apply to the beating heart. The cardiac port of the present invention improves upon the Alfiori method by providing access to the mitral valve without the use of CPB.
- The cardiac port is designed to enable several standard surgical techniques to be performed as minimally invasive surgeries, including bow-tie repair, chordal replacement, and annuloplasty ring placement. The cardiac port of the present invention can be used to place sutures under the guidance of a standard TEE probe, and these sutures can be tied through the cardiac port. During surgical procedures, it is preferred that images be taken of a true short axis to provide the best working view of the mitral valve (short axis is shown in
FIGS. 6A and 6B ), with selected long axis views to orient the instruments within the heart chamber (long axis is shown inFIG. 5 ). - A method of performing mitral valve repair in accordance with the invention will now be explained. As shown in
FIG. 3A , the patient is placed in a right thoracotomy position, with the patient's left side down. This position minimizes the risk of drawing air in during the procedure. A right thoracotomy is performed, using single lung ventilation, as shown inFIG. 3B . The pericardium is opened and the left atrium exposed at the junction of the right pulmonary veins. Alternatively, the heart can be exposed in an identical manner utilizing thoracoscopic techniques, where the ports are placed using a thoracoscope. In all such techniques, low-dose systemic heparinization is utilized. It is envisioned that the below-described procedure can be used in the future with yet-to-be-developed suture placement devices, knot tying techniques, and other instrumentation, including robotic technology. For the present, the open-chest thoracotomy procedure can be used to perform mitral valve repair and other minimally invasive diagnostic and surgical procedures inside of a beating heart. -
FIG. 3C is a schematic of the patient's chest cavity C, as viewed in cross section, during the surgical procedure. The patient's collapsed left lung CL, spine S, heart H, mitral valve MV, and preferred placement of the cardiac port P are shown inFIG. 3C . -
FIG. 3D illustrates the right and left atria RA, LA and the approximate placement of the cardiac port P through the chamber wall CW of the left atria LA during the thoracotomy procedure, which sets the stage for the mitral valve surgery in accordance with the invention. -
FIG. 4 illustrates the anatomy of the heart. Specifically,FIG. 4 shows the left atria LA, right atria RA, and mitral valve MV that separates the left atria LA and left ventricle LV. A block representing the cardiac port P is shown penetrating the chamber wall CW of the left atria LA. It will be understood that the port P shown inFIG. 4 and in the other figures is not necessarily to scale relative to the left atria LA.FIG. 5 also shows the anatomy of the heart. As best seen inFIG. 5 , the mitral valve MV includes an anterior mitral leaflet AML and a posterior mitral leaflet PML. -
FIGS. 6A and 6B schematically illustrate the mitral valve along its short axis, as seen from the left atrium.FIG. 6A shows a normal mitral valve in a closed position.FIG. 6B shows a leaking mitral valve. Encircling the mitral valve is the mitral valve annulus MVA. The mitral valve annulus is the structure that makes up the circumference or ring around the mitral valve. The anterior mitral annulus is defined as that portion of the mitral valve annulus from A to C. The posterior mitral annulus is defined as that portion of the mitral valve annulus from A to B to C. Leaking of the mitral valve can occur due to a torn chordea (labeled X1 and X2 inFIG. 6B , labeled chordea inFIG. 5 ). Leaking can also occur due to dilation of the posterior mitral annulus. When the posterior mitral annulus dilates, the mitral valve leaflets no longer properly come into contact with one another, and the mitral valve leaks. - Turning now to
FIG. 7 , twocardiac ports ports port 40 inFIGS. 2 and 2A , but it will be understood that ports having a different exterior configuration, such as that shown inFIGS. 1 and 1A , can be used in this surgical technique. Prior to their insertion through the chamber wall CW, theports inlets 501, 521 to remove all air from the central lumens of theports Port 50 serves as a main working port.Port 52 is optional and, if inserted through the chamber wall CW, can serve as an auxiliary port to allow passage of a second set of instruments into the heart chamber. - To insert
ports ports respective obturators inlets 501, 521. One end of aline 51, such as a catheter, is attached to the inlet 501 ofport 50, and the other end ofline 51 is inserted percutaneously into a peripheral artery of the patient, such as the femoral artery (not shown). Blood flow through theline 51 and into theport 50 is adjusted by a variable occluder to maintain an atrial pressure of greater than 20 mmHg (i.e., 20 mmHg higher than atmospheric pressure). A variable occluder can include an adjustable clamp to regulate flow. A more sophisticated variable occluder can incorporate a pressure regulating device to keep the atrial pressure from rising to more than, for example, 25 mmHg (i.e., 25 mmHg higher than atmospheric pressure). Atrial pressure is transduced, or measured, through a fluid-filledline 53 placed into the most superior portion of the atrium. Thisline 53 also functions as another de-airing portal when low manual suction is applied to it.FIG. 8 shows a cannulated heart. In an alternative embodiment, a cannula or small tube can be positioned through the chamber wall, and the heart chamber can be pressurized by shunting arterial blood from the patient's artery into the heart chamber via the cannula. - Depending on the patient's morphology, either a transesophageal probe, such as
probe 55 inFIG. 7 , inserted in a standard fashion in the patient's esophagus can be used to image the patient's heart during the surgical procedure, or a sterile echo probe can be inserted directly into the pericardium beneath the heart in the space between the superior and inferior pulmonary veins. As real-time three-dimensional echo, CT and MRI systems become available for operating room use, these will likely supplant TEE as the sole imaging modality. - After identifying the anatomic structures on echo, and assessing the cause of the mitral valve dysfunction, repair is undertaken, as illustrated in
FIGS. 9-14 . Stenotic mitral valves with commissural fusion, where the valve leaflets fuse together, causing the valve opening to become narrow or “stenose,” are manually fractured with a spreading device placed through the port under direct echo guidance. The spreading device, for example, endoscopic scissors, force the valve leaflet edges apart. Regurgitant valves, i.e., valves which regurgitate blood from the ventricle to the atrium, will be treated in the following manner. - Referring to
FIG. 9 , an endoscopicsuture placing device 56 is inserted through the main workingcardiac port 50. If needed, a customized valve hook device and/orgrasper device 65, as shown inFIGS. 9A and 9B , can be inserted through thesecond port 52 to stabilize the valve leaflets AML, PML and to facilitate suture placement by thesuture placing device 56. - The suture has needles at both ends 57, 58. One end of the suture S remains outside of the patient's body under the control of the surgeon at all times to minimize the risk of the suture getting loose in the patient's circulatory system.
FIG. 9 shows the needle on suture end 57 (obscured by device 56) being placed through the anterior mitral leaflet AML, withsuture end 58 remaining outside of the patient's body.FIG. 10 shows the needle on suture end 58 (obscured by device 56) being placed through the posterior mitral leaflet PML, withsuture end 57 remaining outside of the patient's body. - To properly place the suture in
FIG. 9 , thesuture placing device 56 grasps the anterior leaflet AML at its free edge (the whole procedure being done under echo guidance) and fires the suture S through the anterior leaflet AML. Theend 57 of the suture S that has just been fired through the anterior leaflet AML then is brought out of the left atrium LA by thesuture placing device 56 via theport 50. Next, end 58 is loaded into thesuturing device 56, and thesuture placing device 56 is fed back through theport 50 and into the left atrium LA. The appropriate section of the posterior leaflet PML then is grasped by thesuture placing device 56, and thesuture end 58 is fired through the posterior leaflet PML, as shown inFIG. 10 . Thisend 58 of the suture S too is brought out through theport 50, as shown inFIG. 11 . - At this stage of the procedure, the suture S has two suture arms that terminate at ends 57, 58 outside of the
port 50. The suture S is tied using a standardendoscopic knot pusher 59, as shown inFIG. 12 . - A
suture cutting device 60 of the present invention is then run down one arm of the suture S, and the excess suture is trimmed, as shown inFIG. 13 . InFIG. 13 ,suture end 58 is shown extending from thesuture cutting device 60. Thedevice 60 runs down over the suture arm S to avoid cutting other structures and is designed to cut each suture arm S at least 7 mm from the leaflets AML, PML, retaining a tail of at least 3 mm. This procedure avoids accidentally cutting the knot K. Thesuture cutting device 60 is illustrated inFIG. 16 and will be described more fully below. This suture cutting procedure is repeated down the other suture arm. Tying off the suture S in this manner leaves the central portions of the anterior and posterior mitral leaflets AML, PML sewn to one another in the manner of an Alfiori or “bow-tie” mitral valve repair, as seen inFIG. 14 and as is done in conventional open heart surgery. It will be understood that multiple sutures can be placed through the mitral leaflets, if necessary. - In a preferred embodiment of the invention, the
suture cutting device 60 is run down on suture arm at a time to reduce the chance of the knot K being cut. However, it will be understood that, in an alternative embodiment, the suture cutting device can be run down both suture arms at the same time, and both suture arms then would be cut at the same time. - Once the suture has been tied off, the
cardiac ports -
FIGS. 15A and 15B show the mitral valve before and after the above-described surgical procedure.FIG. 15A shows a damaged mitral valve, where the leaflets AML, PML leak, andFIG. 15B shows the mitral valve in its repaired state following the surgical procedure. - The cardiac ports of the present invention can be used in other surgical procedures. For example, if resecurement of one of the chordae to the papillary muscle PM of the ventricle is needed, a curved
suture placement device 61 can be inserted through the lumen ofport 50 and placed across the mitral valve MV, as shown inFIG. 17 . Thesuture placement device 61 then can be fired into the papillary muscle PM. The free ends of the suture then can be brought through the edge of the operative mitral leaflet (here, inFIG. 17 , the anterior mitral leaflet, although, in reality, it is usually the posterior mitral leaflet having the torn chord), as described above in connection withFIGS. 10-14 . - In another example, if a reduction in the posterior mitral annulus is needed to supplement the repair, a stapled annuloplasty can be performed in accordance with the invention. In the stapled annuloplasty procedure, a stapling
device 62 is placed through thecardiac port 50, as shown inFIG. 18 . A row of staples ST is fired along the posterior mitral annulus, running from the left to the right fibrous trigones (approximately at A and C inFIGS. 5A and 5B ). The staples reduce the length of the posterior mitral annulus. The staples ST from thedevice 62 cover a distance of 10 mm when first pushed into the mitral annulus, as shown inFIG. 23A . Firing thedevice 62 causes the staples ST to fold in on themselves, as shown inFIG. 23B . This is shown inFIGS. 19A-19E . Points E and F inFIG. 19A are 10 mm apart before staple firing. Points E and F are 5 mm apart afterwards, as shown inFIG. 19C . By varying the size of theanvil 62A in the tip or head of the staplingdevice 62, seen inFIG. 19B , varying amounts of folding will occur in the staple during firing. The greater the amount of folding that occurs in the staple, the greater the amount of tissue plication that will occur. In one embodiment, for example, the staples ST fold from 10 mm to 7 mm, and, in a second embodiment, the staples ST fold from 10 mm to 5 mm. The staple size and the anvil head size can be varied to change the amount of plication that occurs with staple firing. Referring toFIGS. 19D and 19E , the staple placement can lead to a 30-40% reduction in the length of the posterior mitral annulus, as observed in conventional hand-sewn mitral annuloplasty. The staplingdevice 62 can be made in two types in accordance with the invention, one with individual staples, and one with staples that are connected to one another by a suture or band of material such as DACRON. This connection between staples may help to prevent delayed dilation of the annulus in the spaces between the sutures. -
FIGS. 20A and 20B show a completed mitral valve repair with two “bow-tie” sutures K placed between the anterior and posterior mitral leaflets AML, PML, and a stapled posterior annuloplasty, inserted in the manner described in connection withFIGS. 19D and 19E .FIG. 20A shows the mitral valve in systole (i.e., closed), andFIG. 20B shows the mitral valve in diastole (i.e., open). The staples ST are connected together by a strip of material M. The strip of material M can be DACRON or polyester, for example. The strip maintains the shape of the posterior valve annulus. Should the posterior valve annulus dilate over time between adjacent staples, the strip of material M prevents expansion of the posterior valve annulus from occurring. - A stapled annuloplasty offers advantages over a conventional annuloplasty. In a conventional annuloplasty, reduction of the mitral valve annulus MVA is accomplished by plicating or folding the valve orifice down to a smaller size so that the valve leaflets come into better contact with one another. This reduction can be done with plicating sutures alone or with plicating sutures that are placed through an annuloplasty ring, which is a ring-shaped device of predetermined size, as will be described in more detail in connection with
FIGS. 21-22 . As compared to sutures, staples are easier to place, and staples can be placed using less invasive techniques. In addition, in a beating heart, it may be difficult to accurately place and tie multiple sutures. The sutures might become tangled about one another and would be very difficult to untangle. A stapled annuloplasty therefore provides a technique more suitable for use on a beating heart. - Nevertheless, a conventional annuloplasty ring can be sutured to the mitral valve of a beating heart via a cardiac port in accordance with the invention.
FIGS. 21 and 22 illustrate the placement of a conventionalflexible annuloplasty device 64, for example, an annuloplasty ring, through acardiac port 50 of the present invention. Theannuloplasty ring 64 is flexible and can be inserted through thecardiac port 50 in a sideways orientation. An endoscopic suture device is used to place multiple interrupted sutures through the posterior mitral annulus, as shown inFIG. 21A . Each of these sutures are brought through theannuloplasty ring 64, as would be done in a conventional open mitral annuloplasty. Thering 64 then is flexed and pushed through theport 50. Once the ring is in place at the mitral valve annulus, the sutures then are tied using anendoscopic knot pusher 59 and cut with the suture cutting device 60 (seeFIG. 16 ). Thering 64 remains seated against the mitral valve annulus as shown inFIGS. 22 and 22A . -
FIGS. 22 and 22A show an annuloplasty ring that completely encircles the mitral valve and covers the entire mitral annulus (i.e., both the anterior mitral annulus and posterior mitral annulus). However, it will be understood that, in this procedure in a beating heart, the annuloplasty ring ofFIGS. 22 and 22A can be replaced with an annuloplasty ring that only partially encircles the mitral valve. In particular, it is envisioned that an annuloplasty ring for use in accordance with the invention will includerings 64′ that cover only the posterior mitral annulus, i.e., that portion of the valve annulus encircling the posterior mitral leaflet, as, for example, shown inFIG. 22B . The posterior mitral annulus is the portion of the mitral valve that usually dilates. The anterior mitral annulus usually does not dilate because it is attached to the fibrous central core of the heart, which generally remains the same size. -
FIG. 16 shows asuture cutting device 60 that can be used in the above-described surgical procedures in accordance with the invention. Thesuture cutting device 60 has anelongated body 60B and acentral lumen 60C. The suture cutting device also includes awall member 60W extending into thelumen 60C. Thewall member 60W separates a knot-receivingchamber 70 and a cutting implement 72. The knot-receivingchamber 70 is defined by a first area on a first side of thewall member 60W, and the cutting implement 72 is disposed in thelumen 60C in a second area on an opposite side of thewall member 60W. Theelongated body 60B serves as a protective sheath to isolate the cutting implement from the patient so that the cutting implement cannot cut or cause injury to the heart chamber or other anatomic structures. - The
wall member 60W forms a narrowed portion having a hole or channel 60CH therethrough. The channel 60CH matches the caliber of the suture S. A strand of suture S, i.e., a suture arm, can pass up through the channel 60CH and out of the proximal end 60PE of thedevice 60. In another embodiment, theelongated body 60B can have a suture outlet opening located between thewall member 60W and the proximal end 60PE. Theend 58 of the suture can pass through this suture outlet opening so that the suture does not need to be long enough to extend the entire length of thedevice 60. - The knot-receiving
chamber 70 has a greater diameter than the channel 60CH, such that knots K can be accommodated in the knot-receiving chamber 60CH, but cannot pass through the channel 60CH. The knot-receiving chamber can be approximately 7 mm in length, measured from the distal end 60DE of thebody 60 to a lower limit of the channel 60H. The channel 60CH has a length of approximately 3-5 mm. Thus, when the cutting edge CE of the cutting implement 72 moves from a first (at rest) position to a second (cutting) position to cut the suture S, the uppermost knot K is 3-5 mm away from the cutting edge CE in the second position (i.e., the knot retains a 3-5 mm tail). - The
suture cutting device 60 can be fired, for example, by actuating an actuator, such aspush rod 90, connected to the cutting implement 72. Firing thesuture cutting device 60 drives the cutting implement 72 from the first position to the second position across the suture S. Because the knot K cannot pass through the channel 60CH, the cutting edge CE of the cutting implement cannot cut the knot K. - The
wall member 60W can be annular in shape and can have planar upper and lower surfaces, angled upper and lower surfaces, or a combination thereof. InFIG. 16 , thewall member 60W is shown having an upper surface that is planar in onesection 76 and angled in anothersection 78. The cutting implement 72 can be disposed opposite the angledupper surface 78. In this regard, the cutting implement 72 can slide along the angledupper surface 78 of thewall member 60W from a first (at rest) position, shown inFIG. 16 , to a second (cutting) position in the direction of arrow B. In addition, thewall member 60W can have asurface 80 that acts as a stop for the cutting implement 72. Thisstop surface 80 is located opposite the angledupper surface 78. The cutting implement 72 will travel in the direction of arrow B only until cutting edge CE comes into contact withsurface 80. The cutting implement 72 then will retract to its first (at rest) position. - The stapling
device 62, thesuture cutting device 60, and other medical devices used in the above-described minimally invasive diagnostic and surgical procedures can be attached to robotic arms or can be manually manipulated by the surgeon. - As apparent from the above discussion, the present apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart offer several advantages. For example, due to its unique configuration, the cardiac port of the present invention minimizes air intake into the cardiac chamber, minimizes the risk of emboli, and avoids excessive injury to the cardiac wall. The cardiac port prevents air intake by enabling pressurization of the heart chamber with the patient's own arterial blood. The port extends only a small distance into the intracardiac or intra-chamber area of the heart chamber to avoid inadvertent injury of the chamber wall or valve. Further, the cardiac port may prevent blood loss because it includes at least one valve that prevents blood from leaking out of the cardiac port as instruments are passed through the lumen of the cardiac port.
- Preliminary studies of the apparatuses and methods for minimally invasive cardiac surgery have been undertaken. Specifically, the feasibility of performing surgery under echocardiographic guidance was tested in a water bath with silastic sheets simulating the cardiac chambers. The edges of sheet material can be grasped with stapling devices, but, because operating with two-dimensional cross-sectional images provided by TEE is difficult, improvement in the spatial orientation and image resolution is desired to perform important surgical tasks, such as passing a needle from one instrument to another. It was observed that instrument positioning relative to the transducer is also important. All metal instruments create a shadow as they reflect the echo signal, thus obstructing the view of the target areas.
- In another preliminary study, post-mortem examinations were performed on two swine sacrificed in a laboratory. It was determined that a left thoracotomy would allow direct access to the mitral valve through the left atrial appendage. Additional small ports could be placed in the dome of the left atrium or at the origin of the left superior pulmonary vein. An animal over 50 kg would be large enough for the required instrumentation.
- As a result of the preliminary studies, the following research plan was developed and is in the process of being executed in connection with further studies of the present invention. Purebred Yorkshire female swine (50 to 60 kg) will receive a normal swine food diet and will be housed for a minimum of 1 week. Initial sedation will be achieved with 10 mg/kg IM ketamine. An ear vein then will be cannulated for administration of an infusion of ketamine and thaimylal as needed to supplement anesthesia. The swine will be intubated and ventilated with oxygen at a flow of 2 L/min and isofluorane in a concentration of 1.25%. Isofluorane will be the primary anesthetic agent. Suxamethonium (3 mg IV) will be given as a neuromuscular blocking agent. The femoral vein and both femoral arteries will be cannulated. Continuous pressure monitoring with a pressure transducer advanced to the thoracic aorta will be utilized.
- A left thoracotomy will be performed and the left lung deflated by hilar clamping. Heparin (100 mg/kg) will be given. A standard arterial line will be placed in the left femoral artery and connected, through a stopcock, into the left atrium via an 18 gauge IV catheter to increase left atrial pressure, which will minimize the risk of air introduction. Two purse-string sutures will be placed, one in the left atrial wall and one in the left atrial appendage. Cardiac ports in accordance with the invention will be inserted through the purse-strings and secured.
- A trans-esophageal echo (TEE) probe, such as the OMINIPLANE device marketed by Hewlett-Packard, will be advanced into position and connected to a monitor, such as the SONOS 1000 marketed Hewlett-Packard. The left atrium will then be imaged (imaging planes chosen as described below). Under TEE guidance, the free edge of the posterior leaflet will be grasped, if needed, with an endoscopic grasper, such as a Genzyme Snowden-Pencer. A single mattress suture will be placed across the posterior leaflet by firing a stitching device, for example, the AUTO-STITCH device marketed by United States Surgical Corporation, or by firing an endoscopic suture placing device, which is an instrument that passes a single or double suture through a structure. The procedure will be repeated for the anterior leaflet. Both sutures will be brought out through the cardiac port. The sutures will be tied together through the port, using an endoscopic knot pusher. This will replicate the Alfiori “bow-tie” mitral valve repair.
- Mitral valve function will be examined using TEE. The mitral valve area will be calculated using a standard technique. In brief, under long-axis imaging, transmittal velocities will be measured by an echo Doppler. Using the modified Bernoulli equation, pressure gradients will be calculated. The mitral valve area then can be estimated, using the known pressure half time equation. Video recording will be made. Mitral regurgitation will be estimated by a standard color-flow Doppler technique, and regurgitant jet area and length will be measured.
- The swine will be euthanized with 30 cm of KCL. The mitral valve will be inspected for damage and accuracy of suture placement. It is expected that it will take 3-5 animals to develop the basic surgical technique. In animals 1-3, the emphasis will be on imaging and choosing proper port placement sites. Upper-esophageal, mid-esophageal and transgastric TEE positions will be evaluated. Multichamber imaging will be performed in multiple planes at each level. The appropriate imaging planes for surgical manipulation will be identified. Port placement sites on the atrium will be evaluated to choose which sites will allow the appropriate angles of approach to the dynamic valve without shadowing (blocking the echo signal). By animals 3-5, it is expected that appropriate instrumentation to properly constrain the valve leaflets, stapler device firing, and the tying of suture through ports will be identified. These represent new surgical techniques, and a significant learning curve is anticipated. Animals 5-10 will be utilized to demonstrate the reproducibility of the technique.
- The beating heart valve surgery of the present invention represents a significant departure from current standard therapy. It has the potential to significantly reduce the morbidity and mortality of mitral valve surgery. Performing mitral valve repair on the beating heart, duplicating mitral valve repair techniques with a suturing device, and the substitution of echocardiography for direct visualization are all novel and unique approaches to cardiac surgery. These surgical techniques provide a stepping block for complex intracardiac repairs performed by small robotic devices placed into the heart using real-time three-dimensional echocardiography to guide the robotic devices.
- Given the disclosure of the present invention, one versed in the art will appreciate that there may be other embodiments and modifications within the scope and spirit of the present invention. Accordingly, all modifications attainable by one versed in the art from the present disclosure within the scope and spirit of the present invention are to be included as further embodiments of the present invention. The scope of the present invention accordingly is to be defined as set forth in the appended claims.
- All citations to publications, books, patents, and patent applications set forth herein are incorporated by reference in their entirety.
-
- 1. St. Jude Medical Corporation. 1998: Personal Communication.
- 2. Cohn L H, Ross, M R: Mechanical and bioprosthetic mitral valve replacement, in Edmunds L H J (ed): Cardiac Surgery in the Adult, New York, McGraw-Hill, 1997, pp 1025-1050.
- 3. Cosgrove D M, Sabik J F, Navia J L: Minimally invasive valve operations. Ann. Thorac. Surg. 1998; 65:1535-1538.
- 4. Navia J L, Cosgrove D M: Minimally invasive mitral valve operations [see comments]. Ann. Thorac. Surg. 1996; 62; 1542-1544.
- 5. Aklog L, Adams D H, Couper G S, Gobezie R, Sears S, Cohn L H: Techniques and results of direct-access minimally invasive mitral valve surgery: a paradigm for the future J. Thorac. Cardiovasc. Surg. 1998; 116:705-715.
- 6. Cohn L H, Adams D H, Couper G S, Bichell D P, Rosborough D M, Sears S P, Aranki S F; Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair. Ann. Surg. 1997; 226:421-426.
- 7. Loulmet D F, Carpentier A, Cho P W, Berrebi A, d'Attellis N, Austin C B, Couetil J P, Lajos P: Less invasive techniques for mitral valve surgery. J. Thorac. Cardiovasc. Surg. 1998; 115:772-779.
- 8. Mohr F W, Falk V, Diegeler A, Walther T, van S J, Autschbach R: Minimally invasive port-access mitral valve surgery [see comments]. J. Thorac. Cardiovasc. Surg. 1998; 115:567-574.
- 9. Chitwood W R J. Elbeery J R, Chapman W H, Moran J M, Lust R L, Wooden W A, Deaton D H: Video-assisted minimally invasive mitral valve surgery: the “micro-mitral” operation [see comments]. J. Thorac. Cardiovasc. Surg. 1997; 113:413-414.
- 10. Gundry S R, Shattuck O H, Razzouk A J, del R M, Sardari F F, Bailey L L: Facile minimally invasive cardiac surgery via ministernotomy. Ann. Thorac. Surg 1998; 65:1100-1104.
- 11. Baldwin J C: Editorial (con) re minimally invasive port-access mitral valve surgery [editorial; comment]. J. Thorac. Cardiovasc. Surg. 1998; 115:563-564.
- 12. Buckberg G D, Beyersdorf F, Allen B S, Robertson J M: Integrated myocardial management: background and initial application. J. Card. Surg. 1995; 10:68-89.
- 13. Kirklin J W: Myocardial management during cardiac surgery with cardiopulmonary bypass, in Kirklin John W, Barratt-Boyes Brian G (eds): Cardiac Surgery, New York, Churchill Livingstone, 1993, pp 129-165.
- 14. Gorman R C, Ziats N, Rao A K. Gikakis N, Sun L, Khan M M, Stenach N, Sapatnekar S, Chouhan V, Gorman J H, Niewiarowski S. Colman R W, Anderson J M, Edmunds L H J: Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass [see comments]. J. Thorac. Cardiovac. Surg. 1996; 111:1-11.
- 15. Edmunds L H J: Blood-surface interactions during cardiopulmonary bypass. J. Card. Surg 1993; 8:404-410.
- 16. Chung J H, Gikakis N, Rao A K, Drake T A, Colman R W, Edmunds L H J: Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93:2014-2018.
- 17. Edmunds L H J: Why cardiopulmonary bypass makes patients sick: strategies to control the blood-synthetic surface interface. Adv. Card. Surg. 1995; 6:131-167.
- 18. Edmunds L H J; Inflammatory response to cardiopulmonary bypass. Ann. Thorac. Surg. 1998; 66:S12-S16.
- 19. Downing S W, Edmunds L H J: Release of vasoactive substances during cardiopulmonary bypass [see comments]. Ann. Thorac. Surg. 1992; 54:1236-1243.
- 20. Westaby S, Benetti F J: Less invasive coronary surgery: consensus from the Oxford meeting. Ann. Thorac. Surg. 1996; 62; 924-931.
- 21. Siminelakis S, Bossinakou I, Antoniou F, Pallanza Z, Tolios J, Vasilogiannakopoulou D. Kasapli M, Parigori P, Chlapoutakis E: A study of the effects of extracorporeal circulation on the immunologic system of humans. J. Cardiothorac. Vasc. Anesth. 1996; 10:893-898.
- 22. Gill R, Murkin J M: Neuropsychologic dysfunction after cardiac surgery: what is the problem? J. Cardiothorac. Vasc. Anesth. 1996; 10; 91-98.
- 23. Taylor K M: Brain damage during cardiopulmonary bypass. Ann. Thorac. Surg. 1998; 65:S20-S26.
- 24. Taylor K M: Central nervous system effects of cardiopulmonary bypass. Ann. Thorac. Surg. 1998; 66:S20-S24.
- 25. Roach G W, Kanchuger M, Mangano C M, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham S H, Ley C: Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators [see comments]. N. Engl. J. Med. 1996; 335:1857-1863.
- 26. Jansen E W, Grundeman P F, Borst C, Eefting F, Diephuis J, Nierich A, Lahpor J R, Bredee J J: Less invasive off-pump CABG using a suction device for immobilization: the ‘Octopus’ method. Eur. J. Cardiothorac. Surg. 1997; 12:406-412.
- 27. Takuma S, Homma S: Evaluation of mitral valve disease using transesophageal echocardiography [In Process Citation]. Semin. Thorac. Cardiovasc. Surg. 1998; 10:247-254.
- 28. Daniel W G, Mugge A: Transesophageal echocardiography [see comments]. N. Engl. J. Med. 1995; 332:1268-1279.
- 29. Foster G P, Isselbacher E M, Rose G A, Torchiana D F, Akins C W, Picard M H: Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography. Ann. Thorac. Surg. 1998; 65: 1025-1031.
- 30. Takuma S, Zwas D R. Fard A, Wu H, Chaudhry H, Di T M, Ota T, Homma S: Real-time, 3-dimensional echocardiography acquires all standard 2-dimensional images from 2 volume sets: A clinical demonstration in 45 patients [In Process Citation]. J. Am. Soc. Echocardiogr. 1999; 12:1-6.
- 31. Umana J P, Salehizadeh B, DeRose J J Jr, Nahar T, Lotvin A, Homma S, Oz M C: “Bow-tie” mitral valve repair: an adjuvant technique for ischemic mitral regurgitation. Ann. Thorac. Surg. 1998; 66:1640-1646.
- 32. Morales D L S, Madigan J D, Choudhri A F, Williams M R, Helman D N, Elder J B et al. Development of an off bypass mitral valve repair. The Heart Surgery Forum 2000; 2(2):115-120.
Claims (28)
1.-29. (canceled)
30. A method of treatment, comprising:
inserting a cardiac port into a heart chamber wall while the heart remains beating, wherein the port is comprised of a housing, a lumen, a first valve and a second valve in the lumen, and an inlet through the housing and entering the lumen between the first valve and the second valve;
positioning the housing so that the lumen allows access to an interior of the heart chamber via the lumen through the first valve and the second valve;
inserting a medical instrument into the heart chamber interior via the lumen; and
repairing a defect in the heart with the inserted medical instrument.
31. The method of claim 30 , wherein the repairing comprises performing a surgical technique selected from the group consisting of mitral valve repair, repair of atrial or ventricular septal defects, and endovascular aortic surgery.
32. The method of claim 30 , wherein the housing comprises a first portion and a second portion with a narrower circumference relative to the first portion, the second portion comprising a flange around a lower circumference, and wherein the inserting comprises positioning the heart chamber wall between the first portion and the flange on the second portion of the housing.
33. The method of claim 30 , further comprising:
inserting a catheter into the inlet and into the lumen and into the heart chamber.
34. A system for performing annuloplasty, said system comprising:
a plurality of plication staples suitable for application to a mitral valve annulus; and
a suture or a band of material adapted to be stapled to the mitral valve annulus at fixed positions along the suture or band of material to plicate mitral valve annulus tissue and thereby reduce the length of the mitral valve annulus; wherein the staples and suture or band of material are adapted to be delivered to the mitral valve annulus of a heart while the heart is beating
35. A system as in claim 34 , further comprising an instrument for delivering the staples to the valve annulus and plicating valve annulus tissue while the heart is beating.
36. A system, comprising:
a port adapted to span a wall of an atrium and provide access therethrough
a plurality of plication staples adapted to pass through the port and suitable for application to a mitral valve annulus;
a suture or a band of material adapted to be stapled to the mitral valve annulus at fixed positions along the suture or band of material to plicate mitral valve annulus tissue and thereby reduce the length of the mitral valve annulus wherein the staples and suture or band of material are adapted to be delivered to the mitral valve annulus of a heart while the heart is beating; and
an instrument for delivering the staples to the valve annulus and plicating valve annulus tissue.
37. The system of claim 36 , wherein the port comprises:
a housing having a first end, a second end, and a lumen therethrough;
at least one valve disposed in the housing to open and close the lumen; and
an inlet connected to the housing, the inlet having an inlet passage in fluid communication with the lumen of the housing, the inlet adapted to transmit a fluid between an exterior of the port and the lumen of the housing.
38. The system according to claim 37 , wherein the housing includes a first portion and a second portion, the second portion having a length substantially equal to a thickness of the wall of the atrium.
39. The system according to claim 38 , wherein the second portion is flexible relative to the first portion.
40. The system according to claim 38 , wherein the inlet connects to the housing adjacent a position of the at least one value.
41. The system according to claim 38 , wherein the housing has first and second retainer members to retain the wall of the atrium therebetween.
42. The system according to claim 41 , wherein the first and second retainer members are annular flanges that encircle the exterior surface of the housing.
43. The system according to claim 38 , wherein the housing includes a first portion having a first diameter and a second portion having a second diameter smaller than that of the first portion.
44. The system according to claim 43 , wherein the second portion has a length substantially equal to a thickness of the wall of the atrium.
45. The system according to claim 43 , wherein the second portion is flexible relative to the first portion.
46. The system of claim 36 , wherein the port comprises:
a housing having a first end, a second end, and a lumen therethrough;
at least one valve disposed in the housing to open and close the lumen; and
first and second retainer members on the housing, the first retainer member being spaced from the second retainer member a predetermined distance to anchor the chamber wall between the first and second retainer members.
47. The system according to claim 46 , wherein the first and second retainer members comprise first and second flanges disposed on an exterior surface of the housing.
48. The system according to claim 47 , wherein a portion of the housing between the first flange and the second flange is flexible relative to a remaining portion of the housing.
49. The system according to claim 47 , further comprising an inlet connected to the housing, the inlet having an inlet passage in fluid communication with the lumen of the housing, the inlet passage adapted to transmit a fluid between an exterior of the port and the lumen of the housing.
50. The system of claim 36 , wherein the plurality of plication staples are inserted and folded in on themselves at fixed positions along the mitral valve annulus, thereby reducing the length of the mitral valve annulus.
51. The system of claim 50 , wherein the plurality of plication staples are attached to the suture or band of material.
52. A cardiac port for insertion through a chamber wall of a heart chamber to perform a medical procedure inside of a beating heart, comprising:
a housing having a first end, a second end, and a lumen therethrough the housing comprising a first portion and a second portion, the second portion having a length substantially equal to the thickness of the chamber wall;
a first valve disposed in the housing to open and close the lumen;
a second valve disposed in the house to open and close the lumen; and
an inlet connected to the housing between the first valve and the second valve, the inlet having an inlet passage in fluid communication with the lumen of the housing, the inlet adapted to transmit a fluid between an exterior of the port and the lumen of the housing.
53. The cardiac port of claim 52 , wherein the second portion is flexible relative to the first portion.
54. The cardiac port of claim 52 , wherein the housing comprises first and second retainer members to retain the chamber wall therebetween.
55. The cardiac port of claim 54 , wherein the first and second retainer members are annular flanges that encircle the exterior surface of the housing.
56. The cardiac port of claim 52 , wherein the first portion has a first diameter and the second portion has a second diameter smaller than that of the first portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/060,070 US20080183283A1 (en) | 2000-06-20 | 2008-03-31 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21207500P | 2000-06-20 | 2000-06-20 | |
US09/881,045 US6840246B2 (en) | 2000-06-20 | 2001-06-15 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US10/609,385 US20040024414A1 (en) | 2000-06-20 | 2003-07-01 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US12/060,070 US20080183283A1 (en) | 2000-06-20 | 2008-03-31 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/609,385 Continuation US20040024414A1 (en) | 2000-06-20 | 2003-07-01 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080183283A1 true US20080183283A1 (en) | 2008-07-31 |
Family
ID=26906742
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/881,045 Expired - Fee Related US6840246B2 (en) | 2000-06-20 | 2001-06-15 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US10/609,385 Abandoned US20040024414A1 (en) | 2000-06-20 | 2003-07-01 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US12/060,070 Abandoned US20080183283A1 (en) | 2000-06-20 | 2008-03-31 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/881,045 Expired - Fee Related US6840246B2 (en) | 2000-06-20 | 2001-06-15 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US10/609,385 Abandoned US20040024414A1 (en) | 2000-06-20 | 2003-07-01 | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
Country Status (1)
Country | Link |
---|---|
US (3) | US6840246B2 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110125169A1 (en) * | 2009-11-20 | 2011-05-26 | Peter Karl Johansson | Implantable tissue structure modifiers and methods for using the same |
US8109995B2 (en) | 2002-01-04 | 2012-02-07 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US8361144B2 (en) | 2010-03-01 | 2013-01-29 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
US9119738B2 (en) | 2010-06-28 | 2015-09-01 | Colibri Heart Valve Llc | Method and apparatus for the endoluminal delivery of intravascular devices |
US9375218B2 (en) | 2006-05-03 | 2016-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US9737400B2 (en) | 2010-12-14 | 2017-08-22 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
WO2021252405A1 (en) * | 2020-06-07 | 2021-12-16 | The Board Of Trustees Of The Leland Stanford Junior University | Intraoperative aortic valve visualization test devices and systems and methods for using them |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11395726B2 (en) | 2017-09-11 | 2022-07-26 | Incubar Llc | Conduit vascular implant sealing device for reducing endoleaks |
US11653928B2 (en) | 2018-03-28 | 2023-05-23 | Datascope Corp. | Device for atrial appendage exclusion |
Families Citing this family (260)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) * | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
FR2768324B1 (en) * | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
US20040044350A1 (en) | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US6752813B2 (en) * | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US7604646B2 (en) | 1999-04-09 | 2009-10-20 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
DE60045429D1 (en) | 1999-04-09 | 2011-02-03 | Evalve Inc | Device for heart valve surgery |
US7666204B2 (en) | 1999-04-09 | 2010-02-23 | Evalve, Inc. | Multi-catheter steerable guiding system and methods of use |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US8202315B2 (en) | 2001-04-24 | 2012-06-19 | Mitralign, Inc. | Catheter-based annuloplasty using ventricularly positioned catheter |
US7526112B2 (en) * | 2001-04-30 | 2009-04-28 | Chase Medical, L.P. | System and method for facilitating cardiac intervention |
US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US6776784B2 (en) * | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US20060052821A1 (en) * | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US20070112358A1 (en) * | 2001-09-06 | 2007-05-17 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
US6702835B2 (en) * | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20080015633A1 (en) * | 2001-09-06 | 2008-01-17 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US20080249504A1 (en) | 2007-04-06 | 2008-10-09 | Lattouf Omar M | Instrument port |
US20070270793A1 (en) * | 2001-12-08 | 2007-11-22 | Lattouf Omar M | Methods for endocardial ablation |
US7048754B2 (en) * | 2002-03-01 | 2006-05-23 | Evalve, Inc. | Suture fasteners and methods of use |
US7007698B2 (en) * | 2002-04-03 | 2006-03-07 | Boston Scientific Corporation | Body lumen closure |
US6752828B2 (en) * | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US7758637B2 (en) | 2003-02-06 | 2010-07-20 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8641727B2 (en) | 2002-06-13 | 2014-02-04 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US7666193B2 (en) | 2002-06-13 | 2010-02-23 | Guided Delivery Sytems, Inc. | Delivery devices and methods for heart valve repair |
US7753922B2 (en) | 2003-09-04 | 2010-07-13 | Guided Delivery Systems, Inc. | Devices and methods for cardiac annulus stabilization and treatment |
US9949829B2 (en) | 2002-06-13 | 2018-04-24 | Ancora Heart, Inc. | Delivery devices and methods for heart valve repair |
US9226825B2 (en) | 2002-06-13 | 2016-01-05 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
EP1530441B1 (en) * | 2002-06-13 | 2017-08-02 | Ancora Heart, Inc. | Devices and methods for heart valve repair |
US7753858B2 (en) | 2002-06-13 | 2010-07-13 | Guided Delivery Systems, Inc. | Delivery devices and methods for heart valve repair |
US8287555B2 (en) | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US7883538B2 (en) | 2002-06-13 | 2011-02-08 | Guided Delivery Systems Inc. | Methods and devices for termination |
US20060122633A1 (en) | 2002-06-13 | 2006-06-08 | John To | Methods and devices for termination |
EP1581144A4 (en) | 2002-06-27 | 2007-07-11 | Gen Hospital Corp | Systems for and methods of atrioventricular valve regurgitation and reversing ventricular remodeling |
CA2494758C (en) * | 2002-08-01 | 2013-03-19 | The General Hospital Corporation | Cardiac devices and methods for minimally invasive repair of ischemic mitral regurgitation |
EP1534146B1 (en) * | 2002-08-13 | 2008-01-23 | The General Hospital Corporation | Cardiac devices for percutaneous repair of atrioventricular valves |
US8758372B2 (en) | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
WO2004019826A1 (en) * | 2002-08-29 | 2004-03-11 | Md3 Technologies, Llc | Apparatus for implanting surgical devices |
CN1705462A (en) | 2002-10-21 | 2005-12-07 | 米特拉利根公司 | Method and apparatus for performing catheter-based annuloplasty using local plications |
US20050119735A1 (en) | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
CA2502967A1 (en) * | 2002-10-24 | 2004-05-06 | Boston Scientific Limited | Venous valve apparatus and method |
US6945957B2 (en) * | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US7320083B2 (en) * | 2003-04-23 | 2008-01-15 | Dot Hill Systems Corporation | Apparatus and method for storage controller to deterministically kill one of redundant servers integrated within the storage controller chassis |
US10646229B2 (en) | 2003-05-19 | 2020-05-12 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7534204B2 (en) * | 2003-09-03 | 2009-05-19 | Guided Delivery Systems, Inc. | Cardiac visualization devices and methods |
US7753901B2 (en) * | 2004-07-21 | 2010-07-13 | Tyco Healthcare Group Lp | Laparoscopic instrument and cannula assembly and related surgical method |
US8951275B2 (en) * | 2003-11-20 | 2015-02-10 | Children's Medical Center Corporation | Trocar for use during endoscopy |
US20050137609A1 (en) * | 2003-12-17 | 2005-06-23 | Gerald Guiraudon | Universal cardiac introducer |
US7854761B2 (en) * | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US8864822B2 (en) | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
US7166127B2 (en) * | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US7976539B2 (en) | 2004-03-05 | 2011-07-12 | Hansen Medical, Inc. | System and method for denaturing and fixing collagenous tissue |
US8979922B2 (en) | 2004-03-11 | 2015-03-17 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous heart valve prosthesis |
US8905977B2 (en) * | 2004-07-28 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having an electroactive polymer actuated medical substance dispenser |
US7857183B2 (en) * | 2004-07-28 | 2010-12-28 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating an electrically actuated articulation mechanism |
US7487899B2 (en) * | 2004-07-28 | 2009-02-10 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating EAP complete firing system lockout mechanism |
US7506790B2 (en) * | 2004-07-28 | 2009-03-24 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating an electrically actuated articulation mechanism |
US7410086B2 (en) * | 2004-07-28 | 2008-08-12 | Ethicon Endo-Surgery, Inc. | Electroactive polymer-based actuation mechanism for circular stapler |
US8057508B2 (en) * | 2004-07-28 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating an electrically actuated articulation locking mechanism |
US7862579B2 (en) * | 2004-07-28 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Electroactive polymer-based articulation mechanism for grasper |
US7914551B2 (en) | 2004-07-28 | 2011-03-29 | Ethicon Endo-Surgery, Inc. | Electroactive polymer-based articulation mechanism for multi-fire surgical fastening instrument |
US7513408B2 (en) * | 2004-07-28 | 2009-04-07 | Ethicon Endo-Surgery, Inc. | Multiple firing stroke surgical instrument incorporating electroactive polymer anti-backup mechanism |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US7704277B2 (en) | 2004-09-14 | 2010-04-27 | Edwards Lifesciences Ag | Device and method for treatment of heart valve regurgitation |
US7635329B2 (en) * | 2004-09-27 | 2009-12-22 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8182530B2 (en) * | 2004-10-02 | 2012-05-22 | Christoph Hans Huber | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
AU2006206591B2 (en) * | 2005-01-21 | 2011-08-25 | Mayo Foundation For Medical Education And Research | Thorascopic heart valve repair method and apparatus |
US7854755B2 (en) * | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) * | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7670368B2 (en) * | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
WO2006086434A1 (en) | 2005-02-07 | 2006-08-17 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
WO2011034628A1 (en) | 2005-02-07 | 2011-03-24 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US7867274B2 (en) * | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7784663B2 (en) * | 2005-03-17 | 2010-08-31 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having load sensing control circuitry |
US8864823B2 (en) | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US9492276B2 (en) | 2005-03-25 | 2016-11-15 | St. Jude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
US7722666B2 (en) * | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
SE531468C2 (en) | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
JP2008538937A (en) * | 2005-04-25 | 2008-11-13 | イバルブ・インコーポレーテッド | Apparatus and method for endovascular annuloplasty |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
EP2510883B1 (en) | 2005-06-20 | 2018-04-11 | Nobles Medical Technologies, Inc. | Apparatus for applying a knot to a suture |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US8579936B2 (en) * | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US20070049952A1 (en) * | 2005-08-30 | 2007-03-01 | Weiss Steven J | Apparatus and method for mitral valve repair without cardiopulmonary bypass, including transmural techniques |
US7846179B2 (en) * | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7632308B2 (en) | 2005-11-23 | 2009-12-15 | Didier Loulmet | Methods, devices, and kits for treating mitral valve prolapse |
EP1971280B1 (en) * | 2006-01-05 | 2018-03-07 | Children's Medical Center Corporation | Instrument port for minimally invasive cardiac surgery |
US7799038B2 (en) * | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US7635386B1 (en) * | 2006-03-07 | 2009-12-22 | University Of Maryland, Baltimore | Methods and devices for performing cardiac valve repair |
US7431692B2 (en) * | 2006-03-09 | 2008-10-07 | Edwards Lifesciences Corporation | Apparatus, system, and method for applying and adjusting a tensioning element to a hollow body organ |
US8454683B2 (en) * | 2006-04-12 | 2013-06-04 | Medtronic Vascular, Inc. | Annuloplasty device having a helical anchor and methods for its use |
US7699892B2 (en) | 2006-04-12 | 2010-04-20 | Medtronic Vascular, Inc. | Minimally invasive procedure for implanting an annuloplasty device |
US8932348B2 (en) | 2006-05-18 | 2015-01-13 | Edwards Lifesciences Corporation | Device and method for improving heart valve function |
US20070282429A1 (en) | 2006-06-01 | 2007-12-06 | Hauser David L | Prosthetic insert for improving heart valve function |
US7799073B2 (en) * | 2006-07-12 | 2010-09-21 | Tigran Khalapyan | Annuloplasty system and surgical method |
JP4943796B2 (en) * | 2006-09-29 | 2012-05-30 | テルモ株式会社 | Medical device |
WO2008085814A2 (en) | 2007-01-03 | 2008-07-17 | Mitralsolutions, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
WO2008091493A1 (en) | 2007-01-08 | 2008-07-31 | California Institute Of Technology | In-situ formation of a valve |
JP5604110B2 (en) * | 2007-02-05 | 2014-10-08 | ボストン サイエンティフィック リミテッド | System for delivering a valve |
ES2441801T3 (en) | 2007-02-05 | 2014-02-06 | Boston Scientific Limited | Percutaneous valve and supply system |
WO2008097999A2 (en) | 2007-02-05 | 2008-08-14 | Mitralsolutions, Inc. | Minimally invasive system for delivering and securing an annular implant |
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
US8845723B2 (en) | 2007-03-13 | 2014-09-30 | Mitralign, Inc. | Systems and methods for introducing elements into tissue |
US8911461B2 (en) | 2007-03-13 | 2014-12-16 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US20090043314A1 (en) * | 2007-07-16 | 2009-02-12 | The Cleveland Clinic Foundation | Access device for body tissue and method of using same |
US8828079B2 (en) * | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8657652B2 (en) * | 2007-08-23 | 2014-02-25 | Saint-Gobain Abrasives, Inc. | Optimized CMP conditioner design for next generation oxide/metal CMP |
US8579897B2 (en) | 2007-11-21 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
WO2009052528A2 (en) | 2007-10-18 | 2009-04-23 | Neochord Inc. | Minimially invasive repair of a valve leaflet in a beating heart |
US8480657B2 (en) * | 2007-10-31 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Detachable distal overtube section and methods for forming a sealable opening in the wall of an organ |
US20090112059A1 (en) * | 2007-10-31 | 2009-04-30 | Nobis Rudolph H | Apparatus and methods for closing a gastrotomy |
WO2009061848A2 (en) * | 2007-11-07 | 2009-05-14 | Ovalis, Inc. | Systems devices and methods for achieving transverse orientation in the treatment of septal defects |
US7892276B2 (en) * | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US20090171456A1 (en) * | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
US8790367B2 (en) | 2008-02-06 | 2014-07-29 | Guided Delivery Systems Inc. | Multi-window guide tunnel |
US20110004235A1 (en) * | 2008-02-08 | 2011-01-06 | Sundt Iii Thoralf M | Transapical heart port |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US7972370B2 (en) * | 2008-04-24 | 2011-07-05 | Medtronic Vascular, Inc. | Stent graft system and method of use |
US20090276040A1 (en) | 2008-05-01 | 2009-11-05 | Edwards Lifesciences Corporation | Device and method for replacing mitral valve |
US20090318956A1 (en) * | 2008-05-20 | 2009-12-24 | Belef W Martin | Wire-Like And Other Devices For Treating Septal Defects And Systems And Methods For Delivering The Same |
US8771260B2 (en) * | 2008-05-30 | 2014-07-08 | Ethicon Endo-Surgery, Inc. | Actuating and articulating surgical device |
US8906035B2 (en) * | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
US20100010303A1 (en) * | 2008-07-09 | 2010-01-14 | Ethicon Endo-Surgery, Inc. | Inflatable access device |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
US20100010298A1 (en) * | 2008-07-14 | 2010-01-14 | Ethicon Endo-Surgery, Inc. | Endoscopic translumenal flexible overtube |
BRPI0919672A2 (en) | 2008-10-10 | 2015-12-01 | Guided Delivery Systems Inc | cable tensioning devices and related methods. |
US20100121349A1 (en) | 2008-10-10 | 2010-05-13 | Meier Stephen C | Termination devices and related methods |
EP4321134A3 (en) | 2008-11-21 | 2024-05-01 | Percutaneous Cardiovascular Solutions Pty Limited | Heart valve prosthesis and method |
US20100331622A2 (en) * | 2008-11-25 | 2010-12-30 | Ethicon Endo-Surgery, Inc. | Tissue manipulation devices |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
US20110011917A1 (en) * | 2008-12-31 | 2011-01-20 | Hansen Medical, Inc. | Methods, devices, and kits for treating valve prolapse |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
WO2010085456A1 (en) | 2009-01-20 | 2010-07-29 | Guided Delivery Systems Inc. | Anchor deployment devices and related methods |
US8808371B2 (en) | 2009-01-22 | 2014-08-19 | St. Jude Medical, Cardiology Division, Inc. | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring |
EP2381896B1 (en) * | 2009-01-22 | 2015-10-21 | St. Jude Medical, Cardiology Division, Inc. | Magnetic docking system for the long term adjustment of an implantable device |
US20100191050A1 (en) * | 2009-01-23 | 2010-07-29 | Ethicon Endo-Surgery, Inc. | Variable length accessory for guiding a flexible endoscopic tool |
US20100198248A1 (en) * | 2009-02-02 | 2010-08-05 | Ethicon Endo-Surgery, Inc. | Surgical dissector |
WO2011017440A2 (en) * | 2009-08-06 | 2011-02-10 | Mayo Foundation For Medical Education And Research | Implanting organ ports |
EP2477555B1 (en) | 2009-09-15 | 2013-12-25 | Evalve, Inc. | Device for cardiac valve repair |
US20110077733A1 (en) * | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US20110098694A1 (en) * | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Methods and instruments for treating cardiac tissue through a natural orifice |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8608652B2 (en) * | 2009-11-05 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Vaginal entry surgical devices, kit, system, and method |
US20110112434A1 (en) * | 2009-11-06 | 2011-05-12 | Ethicon Endo-Surgery, Inc. | Kits and procedures for natural orifice translumenal endoscopic surgery |
US20110115891A1 (en) * | 2009-11-13 | 2011-05-19 | Ethicon Endo-Surgery, Inc. | Energy delivery apparatus, system, and method for deployable medical electronic devices |
US8496574B2 (en) | 2009-12-17 | 2013-07-30 | Ethicon Endo-Surgery, Inc. | Selectively positionable camera for surgical guide tube assembly |
US20110152610A1 (en) * | 2009-12-17 | 2011-06-23 | Ethicon Endo-Surgery, Inc. | Intralumenal accessory tip for endoscopic sheath arrangements |
US9028483B2 (en) | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110152923A1 (en) * | 2009-12-18 | 2011-06-23 | Ethicon Endo-Surgery, Inc. | Incision closure device |
US8506564B2 (en) | 2009-12-18 | 2013-08-13 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110190764A1 (en) * | 2010-01-29 | 2011-08-04 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
WO2011129894A2 (en) * | 2010-04-13 | 2011-10-20 | Sentreheart, Inc. | Methods and devices for accessing and delivering devices to a heart |
US9861350B2 (en) | 2010-09-03 | 2018-01-09 | Ancora Heart, Inc. | Devices and methods for anchoring tissue |
US10080659B1 (en) | 2010-12-29 | 2018-09-25 | Neochord, Inc. | Devices and methods for minimally invasive repair of heart valves |
US10092291B2 (en) | 2011-01-25 | 2018-10-09 | Ethicon Endo-Surgery, Inc. | Surgical instrument with selectively rigidizable features |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US9254169B2 (en) | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9314620B2 (en) | 2011-02-28 | 2016-04-19 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
WO2012125785A1 (en) | 2011-03-17 | 2012-09-20 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
AU2012261998B2 (en) | 2011-06-01 | 2017-03-02 | Neochord, Inc. | Minimally invasive repair of heart valve leaflets |
EP3395298A1 (en) | 2011-06-27 | 2018-10-31 | University of Maryland, Baltimore | Transapical mitral valve repair device |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
US20130041395A1 (en) * | 2011-08-09 | 2013-02-14 | Didier De Canniere | Introductory assembly and method for inserting intracardiac instruments |
US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
US9427255B2 (en) | 2012-05-14 | 2016-08-30 | Ethicon Endo-Surgery, Inc. | Apparatus for introducing a steerable camera assembly into a patient |
US9078662B2 (en) | 2012-07-03 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Endoscopic cap electrode and method for using the same |
US9545290B2 (en) | 2012-07-30 | 2017-01-17 | Ethicon Endo-Surgery, Inc. | Needle probe guide |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US9572623B2 (en) | 2012-08-02 | 2017-02-21 | Ethicon Endo-Surgery, Inc. | Reusable electrode and disposable sheath |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
US20140142689A1 (en) | 2012-11-21 | 2014-05-22 | Didier De Canniere | Device and method of treating heart valve malfunction |
DE102013200148A1 (en) | 2013-01-08 | 2014-07-10 | AdjuCor GmbH | Plug system for a cardiac assist device |
DE102013200151A1 (en) | 2013-01-08 | 2014-07-10 | AdjuCor GmbH | Heart support device with markings |
US9220824B2 (en) * | 2013-01-08 | 2015-12-29 | AdjuCor GmbH | Implanting cardiac devices |
US10098527B2 (en) | 2013-02-27 | 2018-10-16 | Ethidcon Endo-Surgery, Inc. | System for performing a minimally invasive surgical procedure |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
WO2015066549A1 (en) | 2013-10-31 | 2015-05-07 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
JP6545696B2 (en) | 2013-11-04 | 2019-07-17 | クイックリング メディカル テクノロジーズ リミテッド | Surgical stapler |
US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
WO2015085145A1 (en) | 2013-12-06 | 2015-06-11 | Med-Venture Investments, Llc | Suturing methods and apparatuses |
US9681864B1 (en) | 2014-01-03 | 2017-06-20 | Harpoon Medical, Inc. | Method and apparatus for transapical procedures on a mitral valve |
US9572666B2 (en) | 2014-03-17 | 2017-02-21 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
JP6714518B2 (en) | 2014-06-18 | 2020-06-24 | ポラレス・メディカル・インコーポレイテッド | Mitral valve implant for treatment of valvular regurgitation |
US10251635B2 (en) | 2014-06-24 | 2019-04-09 | Middle Peak Medical, Inc. | Systems and methods for anchoring an implant |
US10456168B2 (en) | 2014-10-30 | 2019-10-29 | Peter Osypka Stiftung | Transmyocardial insertion unit and its use |
US10842626B2 (en) | 2014-12-09 | 2020-11-24 | Didier De Canniere | Intracardiac device to correct mitral regurgitation |
US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
EP4292551A3 (en) | 2015-03-05 | 2024-01-31 | Ancora Heart, Inc. | Devices of visualizing and determining depth of penetration in cardiac tissue |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
US10980973B2 (en) | 2015-05-12 | 2021-04-20 | Ancora Heart, Inc. | Device and method for releasing catheters from cardiac structures |
PL412629A1 (en) | 2015-06-08 | 2016-12-19 | Innovations For Heart And Vessels Spółka Z Ograniczoną Odpowiedzialnością | Device providing access to the heart inside |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
WO2017059406A1 (en) | 2015-10-01 | 2017-04-06 | Neochord, Inc. | Ringless web for repair of heart valves |
EP3355804B1 (en) | 2015-10-02 | 2020-07-15 | Harpoon Medical, Inc. | Distal anchor apparatus for mitral valve repair |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US9592121B1 (en) | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US11045218B2 (en) * | 2016-01-21 | 2021-06-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Transatrial access for intracardiac therapy |
US10624743B2 (en) | 2016-04-22 | 2020-04-21 | Edwards Lifesciences Corporation | Beating-heart mitral valve chordae replacement |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
CN110381850B (en) | 2016-11-18 | 2023-06-30 | 复心公司 | Myocardial implant load sharing apparatus and method for promoting LV function |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
US10925731B2 (en) | 2016-12-30 | 2021-02-23 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US9877833B1 (en) | 2016-12-30 | 2018-01-30 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US11083580B2 (en) | 2016-12-30 | 2021-08-10 | Pipeline Medical Technologies, Inc. | Method of securing a leaflet anchor to a mitral valve leaflet |
US10478303B2 (en) | 2017-03-13 | 2019-11-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US10653524B2 (en) | 2017-03-13 | 2020-05-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN114587711A (en) | 2017-03-13 | 2022-06-07 | 宝来瑞斯医疗有限公司 | Devices, systems, and methods for transcatheter treatment of valve regurgitation |
US10213306B2 (en) | 2017-03-31 | 2019-02-26 | Neochord, Inc. | Minimally invasive heart valve repair in a beating heart |
US10765515B2 (en) | 2017-04-06 | 2020-09-08 | University Of Maryland, Baltimore | Distal anchor apparatus and methods for mitral valve repair |
US11065119B2 (en) | 2017-05-12 | 2021-07-20 | Evalve, Inc. | Long arm valve repair clip |
US10842619B2 (en) | 2017-05-12 | 2020-11-24 | Edwards Lifesciences Corporation | Prosthetic heart valve docking assembly |
CA3065223C (en) | 2017-06-19 | 2024-05-07 | Harpoon Medical, Inc. | Method and apparatus for cardiac procedures |
EP3641663B1 (en) | 2017-06-19 | 2022-03-02 | Heartstitch, Inc. | Suturing systems and methods for suturing body tissue |
US11591554B2 (en) | 2017-09-11 | 2023-02-28 | Heartstitch, Inc. | Methods and devices for papillary suturing |
CN111372525B (en) | 2017-10-24 | 2023-08-04 | 马里兰大学巴尔的摩分校 | Method and apparatus for cardiac procedure |
EP3720389A1 (en) | 2018-01-22 | 2020-10-14 | Edwards Lifesciences Corporation | Heart shape preserving anchor |
US11547276B2 (en) | 2018-03-09 | 2023-01-10 | The Children's Medical Center Corporation | Optical bulb for surgical instrument port |
US11284788B2 (en) | 2018-03-09 | 2022-03-29 | The Children's Medical Center Corporation | Instrument port with fluid flush system |
US11324555B2 (en) | 2018-03-09 | 2022-05-10 | The Children's Medical Center Corporation | Instrument port including optical bulb secured to port body |
US11213316B2 (en) | 2018-03-09 | 2022-01-04 | The Children's Medical Center Corporation | Gasket with multi-leaflet valve for surgical port apparatus |
JP7083549B2 (en) | 2018-03-23 | 2022-06-13 | ネオコード インコーポレイテッド | Suture attachment device for minimally invasive heart valve repair |
US11517435B2 (en) | 2018-05-04 | 2022-12-06 | Edwards Lifesciences Corporation | Ring-based prosthetic cardiac valve |
US11173030B2 (en) | 2018-05-09 | 2021-11-16 | Neochord, Inc. | Suture length adjustment for minimally invasive heart valve repair |
US11253360B2 (en) | 2018-05-09 | 2022-02-22 | Neochord, Inc. | Low profile tissue anchor for minimally invasive heart valve repair |
AU2019336254B2 (en) | 2018-09-07 | 2021-12-09 | Neochord, Inc. | Device for suture attachment for minimally invasive heart valve repair |
EP3893810A4 (en) | 2018-12-12 | 2022-12-14 | Pipeline Medical Technologies, Inc. | Method and apparatus for mitral valve chord repair |
WO2020214818A1 (en) | 2019-04-16 | 2020-10-22 | Neochord, Inc. | Transverse helical cardiac anchor for minimally invasive heart valve repair |
CA3147413A1 (en) | 2019-07-15 | 2021-01-21 | Ancora Heart, Inc. | Devices and methods for tether cutting |
US11464634B2 (en) | 2020-12-16 | 2022-10-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors |
US11759321B2 (en) | 2021-06-25 | 2023-09-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000739A (en) * | 1975-07-09 | 1977-01-04 | Cordis Corporation | Hemostasis cannula |
US4164943A (en) * | 1977-09-30 | 1979-08-21 | Thoratec Laboratories Corporation | Catheter anchor |
US4281659A (en) * | 1979-03-12 | 1981-08-04 | Roche Medical Electronics Inc. | Applying and securing percutaneous or transcutaneous probes to the skin especially for fetal monitoring |
US4962757A (en) * | 1989-02-28 | 1990-10-16 | Baxter International Inc. | Suture loop for catheters |
US5312355A (en) * | 1991-07-09 | 1994-05-17 | H L Medical Inventions, Inc. | Splittable hemostatic valve and sheath and the method for using the same |
US5332398A (en) * | 1992-02-01 | 1994-07-26 | Board Of Regents, The University Of Texas System | Intramedullary catheter |
US5571215A (en) * | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5591195A (en) * | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
US5797933A (en) * | 1996-07-16 | 1998-08-25 | Heartport, Inc. | Coronary shunt and method of use |
US5814097A (en) * | 1992-12-03 | 1998-09-29 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5849005A (en) * | 1995-06-07 | 1998-12-15 | Heartport, Inc. | Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6228052B1 (en) * | 1996-02-29 | 2001-05-08 | Medtronic Inc. | Dilator for introducer system having injection port |
US6231587B1 (en) * | 1995-10-13 | 2001-05-15 | Transvascular, Inc. | Devices for connecting anatomical conduits such as vascular structures |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6287322B1 (en) * | 1995-12-07 | 2001-09-11 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US20020013621A1 (en) * | 2000-07-27 | 2002-01-31 | Robert Stobie | Heart valve holder for constricting the valve commissures and methods of use |
US20020095167A1 (en) * | 2000-10-23 | 2002-07-18 | Liddicoat John R. | Automated annular plication for mitral valve repair |
US20020138044A1 (en) * | 2000-10-27 | 2002-09-26 | Streeter Richard B. | Intracardiovascular access (ICVATM) system |
US20030018358A1 (en) * | 1999-06-25 | 2003-01-23 | Vahid Saadat | Apparatus and methods for treating tissue |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US6702826B2 (en) * | 2000-06-23 | 2004-03-09 | Viacor, Inc. | Automated annular plication for mitral valve repair |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332402A (en) * | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5972030A (en) * | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
US5797960A (en) * | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5573515A (en) * | 1995-04-20 | 1996-11-12 | Invasatec, Inc. | Self purging angiographic injector |
US6059750A (en) * | 1996-08-01 | 2000-05-09 | Thomas J. Fogarty | Minimally invasive direct cardiac massage device and method |
US6297322B1 (en) * | 1999-09-09 | 2001-10-02 | Baxter International Inc. | Cycloolefin blends and method for solvent bonding polyolefins |
-
2001
- 2001-06-15 US US09/881,045 patent/US6840246B2/en not_active Expired - Fee Related
-
2003
- 2003-07-01 US US10/609,385 patent/US20040024414A1/en not_active Abandoned
-
2008
- 2008-03-31 US US12/060,070 patent/US20080183283A1/en not_active Abandoned
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4000739A (en) * | 1975-07-09 | 1977-01-04 | Cordis Corporation | Hemostasis cannula |
US4164943A (en) * | 1977-09-30 | 1979-08-21 | Thoratec Laboratories Corporation | Catheter anchor |
US4281659A (en) * | 1979-03-12 | 1981-08-04 | Roche Medical Electronics Inc. | Applying and securing percutaneous or transcutaneous probes to the skin especially for fetal monitoring |
US4962757A (en) * | 1989-02-28 | 1990-10-16 | Baxter International Inc. | Suture loop for catheters |
US5312355A (en) * | 1991-07-09 | 1994-05-17 | H L Medical Inventions, Inc. | Splittable hemostatic valve and sheath and the method for using the same |
US5332398A (en) * | 1992-02-01 | 1994-07-26 | Board Of Regents, The University Of Texas System | Intramedullary catheter |
US5814097A (en) * | 1992-12-03 | 1998-09-29 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5571215A (en) * | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5849005A (en) * | 1995-06-07 | 1998-12-15 | Heartport, Inc. | Method and apparatus for minimizing the risk of air embolism when performing a procedure in a patient's thoracic cavity |
US6231587B1 (en) * | 1995-10-13 | 2001-05-15 | Transvascular, Inc. | Devices for connecting anatomical conduits such as vascular structures |
US5591195A (en) * | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
US6287322B1 (en) * | 1995-12-07 | 2001-09-11 | Loma Linda University Medical Center | Tissue opening locator and everter and method |
US6228052B1 (en) * | 1996-02-29 | 2001-05-08 | Medtronic Inc. | Dilator for introducer system having injection port |
US5797933A (en) * | 1996-07-16 | 1998-08-25 | Heartport, Inc. | Coronary shunt and method of use |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6260552B1 (en) * | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6629534B1 (en) * | 1999-04-09 | 2003-10-07 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20030018358A1 (en) * | 1999-06-25 | 2003-01-23 | Vahid Saadat | Apparatus and methods for treating tissue |
US6702826B2 (en) * | 2000-06-23 | 2004-03-09 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US20020013621A1 (en) * | 2000-07-27 | 2002-01-31 | Robert Stobie | Heart valve holder for constricting the valve commissures and methods of use |
US20020095167A1 (en) * | 2000-10-23 | 2002-07-18 | Liddicoat John R. | Automated annular plication for mitral valve repair |
US20020138044A1 (en) * | 2000-10-27 | 2002-09-26 | Streeter Richard B. | Intracardiovascular access (ICVATM) system |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9610158B2 (en) | 2002-01-04 | 2017-04-04 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US8109995B2 (en) | 2002-01-04 | 2012-02-07 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US9554898B2 (en) | 2002-01-04 | 2017-01-31 | Colibri Heart Valve Llc | Percutaneous prosthetic heart valve |
US8790398B2 (en) | 2002-01-04 | 2014-07-29 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US9186248B2 (en) | 2002-01-04 | 2015-11-17 | Colibri Heart Valve Llc | Percutaneously implantable replacement heart valve device and method of making same |
US8900294B2 (en) | 2002-01-04 | 2014-12-02 | Colibri Heart Valve Llc | Method of controlled release of a percutaneous replacement heart valve |
US9125739B2 (en) | 2002-01-04 | 2015-09-08 | Colibri Heart Valve Llc | Percutaneous replacement heart valve and a delivery and implantation system |
US10595861B2 (en) | 2006-05-03 | 2020-03-24 | Datascope Corp. | Systems and methods of tissue closure |
US9375218B2 (en) | 2006-05-03 | 2016-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US11992211B2 (en) | 2006-05-03 | 2024-05-28 | Datascope Corp. | Systems and methods of tissue closure |
US11369374B2 (en) | 2006-05-03 | 2022-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US8821538B2 (en) | 2009-11-20 | 2014-09-02 | Peter Karl Johansson | Implantable tissue structure modifiers and methods for using the same |
US20110125169A1 (en) * | 2009-11-20 | 2011-05-26 | Peter Karl Johansson | Implantable tissue structure modifiers and methods for using the same |
US8361144B2 (en) | 2010-03-01 | 2013-01-29 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve and methods associated therewith |
US9119738B2 (en) | 2010-06-28 | 2015-09-01 | Colibri Heart Valve Llc | Method and apparatus for the endoluminal delivery of intravascular devices |
US10973632B2 (en) | 2010-12-14 | 2021-04-13 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US9737400B2 (en) | 2010-12-14 | 2017-08-22 | Colibri Heart Valve Llc | Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US11564689B2 (en) | 2013-11-19 | 2023-01-31 | Datascope Corp. | Fastener applicator with interlock |
US11395726B2 (en) | 2017-09-11 | 2022-07-26 | Incubar Llc | Conduit vascular implant sealing device for reducing endoleaks |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11701228B2 (en) | 2018-03-20 | 2023-07-18 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11931261B2 (en) | 2018-03-20 | 2024-03-19 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11653928B2 (en) | 2018-03-28 | 2023-05-23 | Datascope Corp. | Device for atrial appendage exclusion |
WO2021252405A1 (en) * | 2020-06-07 | 2021-12-16 | The Board Of Trustees Of The Leland Stanford Junior University | Intraoperative aortic valve visualization test devices and systems and methods for using them |
Also Published As
Publication number | Publication date |
---|---|
US6840246B2 (en) | 2005-01-11 |
US20020161378A1 (en) | 2002-10-31 |
US20040024414A1 (en) | 2004-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6840246B2 (en) | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart | |
US11413033B2 (en) | Heart valve repair using suture knots | |
CN110944600B (en) | Twisting machine device | |
US11944540B2 (en) | Delivery devices for forming a distal anchor for mitral valve repair | |
US11672662B2 (en) | Short-throw tissue anchor deployment | |
US20240099845A1 (en) | Method and apparatus for cardiac procedures | |
US7635386B1 (en) | Methods and devices for performing cardiac valve repair | |
US20240173133A1 (en) | Double expandable tissue anchor | |
Chitwood Jr et al. | Minimally Invasive Videloscopic Mitral Valve Surgery: The Current Role of Surgical Robotics | |
US10213306B2 (en) | Minimally invasive heart valve repair in a beating heart | |
JPH11512950A (en) | Catheter device and method for forming vascular bypass in vivo | |
US20220249232A1 (en) | Implanting grafts to valve leaflets for cardiac procedures | |
US20220387015A1 (en) | Apparatus for approximating sutures in cardiac procedures | |
Folliguet et al. | Robotic aortic valve replacement: case report | |
Lehr et al. | Applications of surgical robotics in cardiac surgery | |
CN109152573A (en) | Distal anchors device and method for mitral valve repair | |
SHAFFER et al. | Implantation 27 of Continuous-Flow Left Ventricular Assist Devices via Sternotomy Technical Considerations | |
Onan et al. | Totally Endoscopic Robotic Management of Failed Percutaneous Atrial Septal Defect Closure with Tricuspid Valve Injury | |
Lehr et al. | Totally endoscopic coronary bypass surgery robotic on pump (TECAB) | |
Gao et al. | Robotic mitral valve surgery | |
Torregrossa et al. | Off-pump coronary revascularization | |
Chitwood Jr | Minimally invasive mitral valve surgery | |
Chitwood Jr | 16 Minimally Invasive Mitral Valve |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY OF MARYLAND, BALTIMORE, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DOWNING, STEPHEN W.;REEL/FRAME:020737/0849 Effective date: 20020208 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |